<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US7632228 - utilized with implantable glucose sensor, cell transplantation and drug ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level"><meta name="DC.contributor" content="James H. Brauker" scheme="inventor"><meta name="DC.contributor" content="Mark C. Shults" scheme="inventor"><meta name="DC.contributor" content="Mark A. Tapsak" scheme="inventor"><meta name="DC.contributor" content="Dexcom, Inc." scheme="assignee"><meta name="DC.date" content="2004-1-29" scheme="dateSubmitted"><meta name="DC.description" content="The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided."><meta name="DC.date" content="2009-12-15" scheme="issued"><meta name="DC.relation" content="US:20030059631:A1" scheme="references"><meta name="DC.relation" content="US:3775182" scheme="references"><meta name="DC.relation" content="US:3898984" scheme="references"><meta name="DC.relation" content="US:3929971" scheme="references"><meta name="DC.relation" content="US:3943918" scheme="references"><meta name="DC.relation" content="US:3964974" scheme="references"><meta name="DC.relation" content="US:3966580" scheme="references"><meta name="DC.relation" content="US:3979274" scheme="references"><meta name="DC.relation" content="US:4024312" scheme="references"><meta name="DC.relation" content="US:4040908" scheme="references"><meta name="DC.relation" content="US:4073713" scheme="references"><meta name="DC.relation" content="US:4076656" scheme="references"><meta name="DC.relation" content="US:4172770" scheme="references"><meta name="DC.relation" content="US:4197840" scheme="references"><meta name="DC.relation" content="US:4215703" scheme="references"><meta name="DC.relation" content="US:4225410" scheme="references"><meta name="DC.relation" content="US:4240889" scheme="references"><meta name="DC.relation" content="US:4253469" scheme="references"><meta name="DC.relation" content="US:4255500" scheme="references"><meta name="DC.relation" content="US:4259540" scheme="references"><meta name="DC.relation" content="US:4260725" scheme="references"><meta name="DC.relation" content="US:4353888" scheme="references"><meta name="DC.relation" content="US:4374013" scheme="references"><meta name="DC.relation" content="US:4388166" scheme="references"><meta name="DC.relation" content="US:4403984" scheme="references"><meta name="DC.relation" content="US:4415666" scheme="references"><meta name="DC.relation" content="US:4418148" scheme="references"><meta name="DC.relation" content="US:4431004" scheme="references"><meta name="DC.relation" content="US:4436094" scheme="references"><meta name="DC.relation" content="US:4442841" scheme="references"><meta name="DC.relation" content="US:4453537" scheme="references"><meta name="DC.relation" content="US:4477314" scheme="references"><meta name="DC.relation" content="US:4484987" scheme="references"><meta name="DC.relation" content="US:4494950" scheme="references"><meta name="DC.relation" content="US:4506680" scheme="references"><meta name="DC.relation" content="US:4534355" scheme="references"><meta name="DC.relation" content="US:4554927" scheme="references"><meta name="DC.relation" content="US:4571292" scheme="references"><meta name="DC.relation" content="US:4577642" scheme="references"><meta name="DC.relation" content="US:4650547" scheme="references"><meta name="DC.relation" content="US:4663824" scheme="references"><meta name="DC.relation" content="US:4671288" scheme="references"><meta name="DC.relation" content="US:4680268" scheme="references"><meta name="DC.relation" content="US:4686044" scheme="references"><meta name="DC.relation" content="US:4689309" scheme="references"><meta name="DC.relation" content="US:4702732" scheme="references"><meta name="DC.relation" content="US:4703756" scheme="references"><meta name="DC.relation" content="US:4711251" scheme="references"><meta name="DC.relation" content="US:4721677" scheme="references"><meta name="DC.relation" content="US:4731726" scheme="references"><meta name="DC.relation" content="US:4753652" scheme="references"><meta name="DC.relation" content="US:4757022" scheme="references"><meta name="DC.relation" content="US:4759828" scheme="references"><meta name="DC.relation" content="US:4776944" scheme="references"><meta name="DC.relation" content="US:4781798" scheme="references"><meta name="DC.relation" content="US:4787398" scheme="references"><meta name="DC.relation" content="US:4803243" scheme="references"><meta name="DC.relation" content="US:4805625" scheme="references"><meta name="DC.relation" content="US:4810470" scheme="references"><meta name="DC.relation" content="US:4823808" scheme="references"><meta name="DC.relation" content="US:4852573" scheme="references"><meta name="DC.relation" content="US:4861830" scheme="references"><meta name="DC.relation" content="US:4871440" scheme="references"><meta name="DC.relation" content="US:4883057" scheme="references"><meta name="DC.relation" content="US:4889744" scheme="references"><meta name="DC.relation" content="US:4890620" scheme="references"><meta name="DC.relation" content="US:4902294" scheme="references"><meta name="DC.relation" content="US:4927407" scheme="references"><meta name="DC.relation" content="US:4935345" scheme="references"><meta name="DC.relation" content="US:4953552" scheme="references"><meta name="DC.relation" content="US:4963595" scheme="references"><meta name="DC.relation" content="US:4970145" scheme="references"><meta name="DC.relation" content="US:4984929" scheme="references"><meta name="DC.relation" content="US:4986271" scheme="references"><meta name="DC.relation" content="US:4986671" scheme="references"><meta name="DC.relation" content="US:4994167" scheme="references"><meta name="DC.relation" content="US:5002572" scheme="references"><meta name="DC.relation" content="US:5007929" scheme="references"><meta name="DC.relation" content="US:5050612" scheme="references"><meta name="DC.relation" content="US:5059654" scheme="references"><meta name="DC.relation" content="US:5067491" scheme="references"><meta name="DC.relation" content="US:5101814" scheme="references"><meta name="DC.relation" content="US:5113871" scheme="references"><meta name="DC.relation" content="US:5130231" scheme="references"><meta name="DC.relation" content="US:5137028" scheme="references"><meta name="DC.relation" content="US:5165407" scheme="references"><meta name="DC.relation" content="US:5171689" scheme="references"><meta name="DC.relation" content="US:5190041" scheme="references"><meta name="DC.relation" content="US:5222980" scheme="references"><meta name="DC.relation" content="US:5235003" scheme="references"><meta name="DC.relation" content="US:5249576" scheme="references"><meta name="DC.relation" content="US:5264104" scheme="references"><meta name="DC.relation" content="US:5269891" scheme="references"><meta name="DC.relation" content="US:5271736" scheme="references"><meta name="DC.relation" content="US:5282848" scheme="references"><meta name="DC.relation" content="US:5285513" scheme="references"><meta name="DC.relation" content="US:5299571" scheme="references"><meta name="DC.relation" content="US:5304468" scheme="references"><meta name="DC.relation" content="US:5310469" scheme="references"><meta name="DC.relation" content="US:5314471" scheme="references"><meta name="DC.relation" content="US:5316008" scheme="references"><meta name="DC.relation" content="US:5321414" scheme="references"><meta name="DC.relation" content="US:5804048" scheme="references"><meta name="DC.relation" content="US:6528584" scheme="references"><meta name="DC.relation" content="US:RE31916" scheme="references"><meta name="citation_reference" content="Answers.com. &quot;xenogenic.&quot; The American Heritage Stedman&#39;s Medical Dictionary. Houghton Mifflin Company, 2002. Answers.com Nov. 7, 2006 http://www.Answers.com/topic/xenogenic."><meta name="citation_reference" content="Armour, et al. Dec. 1990. Application of Chronic Intravascular Blood Glucose Sensor in Dogs. Diabetes 39:1519-1526."><meta name="citation_reference" content="Atanasov, et al. Biosensor for Continuous Glucose Monitoring. Biotechnology and Bioengineering 1994, 43, 262-266."><meta name="citation_reference" content="Baker, et al. Dynamic concentration challenges for biosensor characterization. Biosens Bioelectron 1993, 8, 433-441."><meta name="citation_reference" content="Bani Amer, M. M. An accurate amperometric glucose sensor based glucometer with eliminated cross-sensitivity. J Med Eng Technol 2002, 26, 208-13."><meta name="citation_reference" content="Beach, et al. Subminiature implantable potentiostat and modified commercial telemetry device for remote glucose monitoring. IEEE Transactions on Instrumentation and Measurement 1999, 48, 1239-1245."><meta name="citation_reference" content="Bindra et al. 1991. Design and In Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring. Anal. Chem 63:1692-96."><meta name="citation_reference" content="Bindra, et al. Pulsed amperometric detection of glucose in biological fluids at a surface-modified gold electrode. Anal Chem 1989, 61, 2566-2570."><meta name="citation_reference" content="Bode, B. W. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther 2000, 2 Suppl 1, S35-41."><meta name="citation_reference" content="Bode, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999, 46, 183-190."><meta name="citation_reference" content="Bode, et al. Using the continuous glucose monitoring system to improve the management of type 1 diabetes. Diabetes Technol Ther 2000, 2 Suppl 1, S43-8."><meta name="citation_reference" content="Bott, A. W. A Comparison of Cyclic Voltammetryand Cyclic Staircase Voltammetry. Current Separations 1997, 16:1, 23-26."><meta name="citation_reference" content="Brauker, et al. Jun. 27, 1996. Local Inflammatory Response Around Diffusion Chambers Containing Xenografts Transplantation 61(12):1671-1677."><meta name="citation_reference" content="Brauker, et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 1995, 29, 1517-1524."><meta name="citation_reference" content="Brauker, et al. Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Hum Gene Ther 1998, 9, 879-888."><meta name="citation_reference" content="Brauker, J., Abstract: Neovascularization of Cell Transplantation Devices: Membrane Architecture-Driven an Implanted Tissue-Driven Vascularization. Baxter Healthcare Corp."><meta name="citation_reference" content="Brauker, J.H. Unraveling Mysteries at the Biointerface: Molecular Mediator of Inhibition of Blood Vessel Formation in the Foreign Body Capsule Revealed. Surfacts Biomaterials 2001,6, 1;5."><meta name="citation_reference" content="Bremer, et al. Benchmark data from the literature for evaluation of new glucose sensing technologies. Diabetes Technol Ther 2001, 3, 409-418."><meta name="citation_reference" content="Brunner, et al. Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care 1998, 21, 585-590."><meta name="citation_reference" content="D&#39;Arrigo, et al. Porous-Si based bioreactors for glucose monitoring and drugs production. Proc. of SPIE 2003, 4982, 178-184."><meta name="citation_reference" content="Direct 30/30(R) meter (Markwell Medical) (Catalog), date unknown."><meta name="citation_reference" content="Dixon, et al. Characterization in vitro and in vivo of the oxygen dependence of an enzyme/polymer biosensor for monitoring brain glucose. J Neurosci Methods 2002, 119, 135-142."><meta name="citation_reference" content="DuPont1 Dimension AR(R) (Catalog), date unknown."><meta name="citation_reference" content="Ernst, et al. Reliable glucose monitoring through the use of microsystem technology. Anal Bioanal Chem 2002, 373, 758-761."><meta name="citation_reference" content="Fare, et al. Functional characterization of a conducting polymer-based immunoassay system. Biosens Bioelectron 1998, 13, 459-470."><meta name="citation_reference" content="Fischer et al. 1989. Oxygen Tension at the Subcutaneous Implantation Site of Glucose Sensors. Biomed. Biochem 11/12:965-972."><meta name="citation_reference" content="Frost, et al. Implantable chemical sensors for real-time clinical monitoring: progress and challenges. Curr Opin Chem Biol 2002, 6, 633-641."><meta name="citation_reference" content="Geller, et al. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Ann NY Acad Sci 1997, 831, 438-451."><meta name="citation_reference" content="Gerritsen, et al. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res 2001, 54, 69-75."><meta name="citation_reference" content="Gerritsen, et al. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med 1999, 54, 167-179."><meta name="citation_reference" content="Gerritsen, M. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care 2000, 23, 143-5."><meta name="citation_reference" content="Gilligan et al. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 1994, 17:8, 882-887."><meta name="citation_reference" content="Gough, et al. Immobilized glucose oxidase in implantable glucose sensor technology. Diabetes Technol Ther 2000, 2, 377-380."><meta name="citation_reference" content="Gross, et al. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000, 2 Suppl 1, S19-26."><meta name="citation_reference" content="Gross, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000, 2, 49-56."><meta name="citation_reference" content="Gross, Todd, &quot;Letters to the Editor Re: Diabetes Technology &amp; Therapeutics, 2000;2:49-56,&quot; vol. 3, No. 1, p. 130-131, 2001."><meta name="citation_reference" content="Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part 1. An adsorption-controlled mechanism. Electrochimica Acta 1998, 43, 579-588."><meta name="citation_reference" content="Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part II: effect of potential. Electrochimica Acta 1998, 43, 2015-2024."><meta name="citation_reference" content="Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part III: Effect of temperature. Electrochimica Acta 1999, 44, 2455-2462."><meta name="citation_reference" content="Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part IV: phosphate buffer dependence. Electrochimica Acta 1999, 44, 4573-4582."><meta name="citation_reference" content="Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part V: inhibition by chloride. Electrochimica Acta 2000, 45, 3573-3579."><meta name="citation_reference" content="Hitchman, M. Measurement of Dissolved Oxygen. Chemical Analysis 1978, 49, 34-123."><meta name="citation_reference" content="Huang, C., O&#39;Grady, W.E.; Yeager, E. Electrochemical Generation of Oxygen. 1: The Effects of Anions and Cations on Hydrogen Chemisorption and Aniodic Oxide Film Formation on Platinum Electrode. 2: The Effects of Anions and Cations on Oxygen Generation on Platinum Electrode, pp. 1-116, Aug. 1975."><meta name="citation_reference" content="IPER for PCT/US02/23902 filed Jul. 26, 2002."><meta name="citation_reference" content="ISR for PCT/US02/23902 filed Jul. 26, 2002."><meta name="citation_reference" content="Jensen, et al. Fast Wave Forms for Pulsed Electrochemical Detection of Glucose by Incorporation of Reduction Desorption of Oxidation Products. Analytical Chemistry 1997, 69, 1776-1781."><meta name="citation_reference" content="Johnson, et al. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosens Bioelectron 1992, 7, 709-714."><meta name="citation_reference" content="Jovanovic, L. The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technol Ther 2000, 2 Suppl 1, S67-71."><meta name="citation_reference" content="Kargol, et al. Studies on the structural properties of porous membranes: measurement of linear dimensions of solutes. Biophys Chem 2001, 91, 263-271."><meta name="citation_reference" content="Kaufman, F. R. Role of the continuous glucose monitoring system in pediatric patients. Diabetes Technol Ther 2000, 2 Suppl 1, S49-52."><meta name="citation_reference" content="Kiechle, F.L. The impact of continuous glucose monitoring on hospital point-of-care testing programs. Diabetes Technol Ther 2001, 3, 647-649."><meta name="citation_reference" content="Koschinsky, et al. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev 2001, 17, 113-123."><meta name="citation_reference" content="Kruger, et al. Psychological motivation and patient education: a role for continuous glucose monitoring. Diabetes Technol Ther 2000, 2 Suppl 1, S93-7."><meta name="citation_reference" content="Lee, et al. Effects of pore size, void volume, and pore connectivity on tissue responses. Society for Biomaterials 1999, 25th Annual Meeting, 171."><meta name="citation_reference" content="Lerner, et al. An implantable electrochemical glucose sensor. Ann N Y Acad Sci 1984, 428, 263-278."><meta name="citation_reference" content="Leypoldt, et al. Model of a two-substrate enzyme electrode for glucose. Anal Chem 1984, 56, 2896-2904."><meta name="citation_reference" content="Loffler, et al. 1995. Separation and determination of traces of ammonia in air by means of chromatomembrane cells. Fresenius J Anal Chem 352:613-614."><meta name="citation_reference" content="lshikawa, et al. Initial evaluation of a 290-microm diameter subcutaneous glucose sensor: glucose monitoring with a biocompatible, flexible-wire, enzyme-based amperometric microsensor in diabetic and nondiabetic humans. J Diabetes Complications 1998, 12, 295-301."><meta name="citation_reference" content="Lyman D. 1960. Polyurethanes. I. The Solution Polymerization of Diisocyanates with Ethylene Glycol. J. Polymer Sci XLV:45:49."><meta name="citation_reference" content="Makale, et al. Tissue window chamber system for validation of implanted oxygen sensors. Am J Physiol Heart Circ Physiol 2003, 284, 1-24."><meta name="citation_reference" content="Malin, et al. Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectroscopy. Clinical Chemistry, 45:9, 1651-1658, 1999."><meta name="citation_reference" content="McKean, et al. Jul. 7, 1988. A Telemetry Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors. Transactions on Biomedical Engineering 35:526-532."><meta name="citation_reference" content="Office Action dated Apr. 4, 2006 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Apr. 9, 2003 in U.S. Appl. No. 09/916,386."><meta name="citation_reference" content="Office Action dated Aug. 1, 2006 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Aug. 14, 2001 in U.S. Appl. No. 09/489,588."><meta name="citation_reference" content="Office Action dated Aug. 14, 2006 in U.S. Appl. No. 11/039,269."><meta name="citation_reference" content="Office Action dated Aug. 15, 2001 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Dec. 7, 1998 in U.S. Appl. No. 08/811,473."><meta name="citation_reference" content="Office Action dated Feb. 24, 2006 in U.S. Appl. No. 10/646,333."><meta name="citation_reference" content="Office Action dated Feb. 24, 2006 in U.S. Appl. No. 11/039,269."><meta name="citation_reference" content="Office Action dated Feb. 27, 2002 in U.S. Appl. No. 09/489,588."><meta name="citation_reference" content="Office Action dated Jan. 16, 2003 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Jan. 17, 2002 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Jul. 15, 2002 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Jul. 17, 2007 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Jul. 9, 2003 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Jun. 12, 2003 in U.S. Appl. No. 09/489,588."><meta name="citation_reference" content="Office Action dated Jun. 6, 2003 in U.S. Appl. No. 10/646,333."><meta name="citation_reference" content="Office Action dated Mar. 22, 2004 in U.S. Appl. No. 09/916,858."><meta name="citation_reference" content="Office Action dated Mar. 9, 2007 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated May 23, 2007 in U.S. Appl. No. 11/055,779."><meta name="citation_reference" content="Office Action dated May 4, 2005 in U.S. Appl. No. 11/039,269."><meta name="citation_reference" content="Office Action dated Nov. 2, 2005 in U.S. Appl. No. 11/039,269."><meta name="citation_reference" content="Office Action dated Nov. 28, 2003 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Office Action dated Oct. 16, 2006 in U.S. Appl. No. 10/647,065."><meta name="citation_reference" content="Office Action dated Sep. 21, 2004 in U.S. Appl. No. 09/916,858."><meta name="citation_reference" content="Office Action dated Sep. 21, 2004 in U.S. Appl. No. 10/657,843."><meta name="citation_reference" content="Office Action dated Sep. 21, 2007 in U.S. Appl. No. 10/838,912."><meta name="citation_reference" content="Office Action dated Sep. 22, 2004 in U.S. Appl. No. 10/646,333."><meta name="citation_reference" content="Office Action dated Sep. 22, 2005 in U.S. Appl. No. 09/447,227."><meta name="citation_reference" content="Phillips and Smith. 1988. Bromedical Applications of Polyurethanes: Implications of Failure Mechanisms. J. Biomat. Appl. 3:202-227."><meta name="citation_reference" content="Pineda, et al. 1996. Bone regeneration with resorbable polymeric membranes. III. Effect of poly(L-lactide) membrane pore size on the bone healing process in large defects. J. Biomedical Materials Research 31:385-394."><meta name="citation_reference" content="Shichiri, et al. 1986. Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals. Diabetes Care, Inc. 9(3):208-301."><meta name="citation_reference" content="Stokes. 1988. Polyether Polyurethanes: Biostable or Not? J. Biomat. Appl. 3:228-259."><meta name="citation_reference" content="Tse and Gough. 1987. Time-Dependent Inactivation of Immobilized Glucose Oxidase and Catalase. Biotechnol. Bioeng. 29:705-713."><meta name="citation_reference" content="Updike et al. 1988. Laboratory Evaluation of New Reusable Blood Glucose Sensor. Diabetes Care 11:801-807."><meta name="citation_reference" content="Updike, et al. 1982. Implanting the glucose enzyme electrode: Problems, progress, and alternative solutions. Diabetes Care 5(3):207-212."><meta name="citation_reference" content="Woodward. 1982. How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensor. Diabetes Care 5:278-281."><meta name="citation_patent_number" content="US:7632228"><meta name="citation_patent_application_number" content="US:10/768,889"><link rel="canonical" href="http://www.google.com/patents/US7632228"/><meta property="og:url" content="http://www.google.com/patents/US7632228"/><meta name="title" content="Patent US7632228 - utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level"/><meta name="description" content="The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided."/><meta property="og:title" content="Patent US7632228 - utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("cIntU82OGuPLsATzqYKABg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("FRA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("cIntU82OGuPLsATzqYKABg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("FRA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us7632228?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US7632228"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=rcLxBQABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS7632228&amp;usg=AFQjCNF7IR3FV5uEyq9U1NiCXTgasmr02Q" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US7632228.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US7632228.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20040186362"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US7632228"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US7632228" style="display:none"><span itemprop="description">The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation...</span><span itemprop="url">http://www.google.com/patents/US7632228?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US7632228 - utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US7632228 - utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level" title="Patent US7632228 - utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US7632228 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 10/768,889</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Dec 15, 2009</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jan 29, 2004</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jul 27, 2001</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/DE60209498D1">DE60209498D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE60209498T2">DE60209498T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1414504A2">EP1414504A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1414504B1">EP1414504B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1656958A1">EP1656958A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6702857">US6702857</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20030023317">US20030023317</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20040186362">US20040186362</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20100087724">US20100087724</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO2003011354A2">WO2003011354A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO2003011354A3">WO2003011354A3</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">10768889, </span><span class="patent-bibdata-value">768889, </span><span class="patent-bibdata-value">US 7632228 B2, </span><span class="patent-bibdata-value">US 7632228B2, </span><span class="patent-bibdata-value">US-B2-7632228, </span><span class="patent-bibdata-value">US7632228 B2, </span><span class="patent-bibdata-value">US7632228B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22James+H.+Brauker%22">James H. Brauker</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Mark+C.+Shults%22">Mark C. Shults</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Mark+A.+Tapsak%22">Mark A. Tapsak</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Dexcom,+Inc.%22">Dexcom, Inc.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US7632228.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7632228.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7632228.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (105),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (99),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (5),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (28),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (6)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/7632228&usg=AFQjCNHN-BDOKqU99DuBuDXCwxsF4N8M9A">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D7632228&usg=AFQjCNEzO5ViA8D_vcupe5if-tp9lyTNYA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D7632228B2%26KC%3DB2%26FT%3DD&usg=AFQjCNE33npCHKWIrz2y_sFMwuytaVd8vg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT130080910" lang="EN" load-source="ifi">utilized with implantable glucose sensor, cell transplantation and drug delivery devices ( pumps or microcapsule), and electrical signal delivering or measuring devices; supports tissue ingrowth; interferes with barrier cell layer formation; monitoring glucose level</invention-title></span><br><span class="patent-number">US 7632228 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA67215327" lang="EN" load-source="patent-office"> <div num="p-0001" class="abstract">The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(10)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00000.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00000.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00001.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00001.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00002.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00002.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00003.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00003.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00004.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00004.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00005.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00005.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00006.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00006.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00007.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00007.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00008.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00008.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7632228B2/US07632228-20091215-D00009.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7632228B2/US07632228-20091215-D00009.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(45)</span></span></div><div class="patent-text"><div mxw-id="PCLM27961912" lang="EN" load-source="patent-office" class="claims">
    <div class="claim"> <div id="CLM-00001" num="00001" class="claim">
      <div class="claim-text">1. A biointerface membrane, the membrane comprising:
<div class="claim-text">a first domain, wherein the first domain comprises a solid portion having a plurality of interconnected cavities therein that form an architecture that supports tissue in ingrowth and interferes with barrier cell layer formation, wherein the solid portion comprises silicone; and</div>
<div class="claim-text">a second domain, wherein the second domain is permeable to the passage of an analyte and is impermeable to cells or cell processes.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00002" num="00002" class="claim">
      <div class="claim-text">2. The biointerface membrane according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the cavities form a cavernous configuration with greater than one cavity in three dimensions substantially throughout the entirety of the first domain.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00003" num="00003" class="claim">
      <div class="claim-text">3. The biointerface membrane according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the cavities are formed in a plurality of layers, each layer having different cavity dimensions.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00004" num="00004" class="claim">
      <div class="claim-text">4. The biointerface membrane according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein a substantial number of the cavities are from about 20 microns to about 2000 microns in at least one dimension.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00005" num="00005" class="claim">
      <div class="claim-text">5. The biointerface membrane according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein a substantial number of the cavities are from about 25 microns to about 1000 microns in at least one dimension.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00006" num="00006" class="claim">
      <div class="claim-text">6. The biointerface membrane according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the second domain comprises a biostable material.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00007" num="00007" class="claim">
      <div class="claim-text">7. The biointerface membrane according to <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the biostable material comprises a hydrophobic portion and a hydrophilic portion.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00008" num="00008" class="claim">
      <div class="claim-text">8. The biointerface membrane according to <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the biostable material comprises polyurethane.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00009" num="00009" class="claim">
      <div class="claim-text">9. The biointerface membrane according to <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the biostable material comprises polyurethane and a hydrophilic polymer.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00010" num="00010" class="claim">
      <div class="claim-text">10. The biointerface membrane according to <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the biostable material comprises polyurethane and polyvinylpyrrolidone.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00011" num="00011" class="claim">
      <div class="claim-text">11. The biointerface membrane according to <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the bio stable material comprises silicone and a hydrophilic component.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00012" num="00012" class="claim">
      <div class="claim-text">12. The biointerface membrane according to <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the biostable material comprises silicone and polyethylene glycol.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00013" num="00013" class="claim">
      <div class="claim-text">13. An implantable device, the device comprising a biointerface membrane, the membrane comprising a first domain and a second domain, wherein the first domain is distal to the implantable device, wherein the first domain comprises a solid portion comprising silicone and having a plurality of interconnected cavities therein that form a cavernous configuration with greater than one cavity in three dimensions substantially throughout the entirety of the first domain, wherein the second domain is proximal to the implantable device, and wherein the second domain is permeable to the passage of a chemical and is impermeable to cells or cell processes.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00014" num="00014" class="claim">
      <div class="claim-text">14. The implantable device of <claim-ref idref="CLM-00013">claim 13</claim-ref>, comprising an analyte sensor.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00015" num="00015" class="claim">
      <div class="claim-text">15. The implantable device of <claim-ref idref="CLM-00013">claim 13</claim-ref>, comprising a glucose sensor.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00016" num="00016" class="claim">
      <div class="claim-text">16. The implantable device of <claim-ref idref="CLM-00013">claim 13</claim-ref>, comprising a cell transplantation device.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00017" num="00017" class="claim">
      <div class="claim-text">17. The implantable device of <claim-ref idref="CLM-00013">claim 13</claim-ref>, comprising a drug delivery device.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00018" num="00018" class="claim">
      <div class="claim-text">18. The implantable device of <claim-ref idref="CLM-00017">claim 17</claim-ref>, wherein the drug delivery device is selected from the group consisting of a pump, a microcapsule, and a macrocapsule.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00019" num="00019" class="claim">
      <div class="claim-text">19. The implantable device of <claim-ref idref="CLM-00013">claim 13</claim-ref>, comprising an electrical signal measuring device.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00020" num="00020" class="claim">
      <div class="claim-text">20. The implantable device of <claim-ref idref="CLM-00013">claim 13</claim-ref>, comprising an electrical pulse delivering device.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00021" num="00021" class="claim">
      <div class="claim-text">21. A method of monitoring an analyte level, the method comprising:
<div class="claim-text">implanting an implantable analyte sensor in a host, the sensor comprising a biointerface membrane, the membrane comprising a first domain and a second domain, wherein the first domain is distal to the implantable device, wherein the first domain comprises a solid portion comprising silicone and having a plurality of interconnected cavities therein that form an architecture that supports tissue ingrowth and interferes with barrier cell layer formation, wherein the second domain is proximal to the implantable device, and wherein the second domain is permeable to the passage of an analyte and is impermeable to cells or cell processes; and</div>
<div class="claim-text">monitoring an analyte level.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00022" num="00022" class="claim">
      <div class="claim-text">22. The method according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein implanting the sensor in the host comprises implanting the sensor in a subcutaneous tissue of a host.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00023" num="00023" class="claim">
      <div class="claim-text">23. The method according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein the analyte sensor is configured to permit accurate continuous analyte sensing.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00024" num="00024" class="claim">
      <div class="claim-text">24. The method according to <claim-ref idref="CLM-00021">claim 21</claim-ref>, wherein implanting the sensor in the host comprises implanting the sensor in a subcutaneous tissue of a host.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00025" num="00025" class="claim">
      <div class="claim-text">25. An implantable device, the device comprising:
<div class="claim-text">a membrane, the membrane comprising a biointerface region comprising a cavernous first portion and a non-cavernous second portion, wherein the non-cavernous second portion is resistant to cellular attachment, cells, or cell processes, and wherein the non-cavernous second portion is permeable to the passage of at least one chemical, wherein the cavernous first portion comprises a plurality of interconnected cavities and has greater than one cavity in three dimensions substantially throughout the entirety of the cavernous first portion.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00026" num="00026" class="claim">
      <div class="claim-text">26. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the cavernous first portion comprises a solid portion formed with the plurality of interconnected cavities therein and configured to support tissue ingrowth and interfere with barrier cell layer formation.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00027" num="00027" class="claim">
      <div class="claim-text">27. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein a substantial number of the cavities are from about 20 microns to about 2000 microns in at least one dimension.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00028" num="00028" class="claim">
      <div class="claim-text">28. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein a substantial number of the cavities are from about 25 microns to about 1000 microns in at least one dimension.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00029" num="00029" class="claim">
      <div class="claim-text">29. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the cavities are formed in a plurality of layers, each layer having different cavity dimensions.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00030" num="00030" class="claim">
      <div class="claim-text">30. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the second portion comprises a biostable material.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00031" num="00031" class="claim">
      <div class="claim-text">31. The implantable device according to <claim-ref idref="CLM-00030">claim 30</claim-ref>, wherein the biostable material comprises a hydrophobic portion and a hydrophilic portion.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00032" num="00032" class="claim">
      <div class="claim-text">32. The implantable device according to <claim-ref idref="CLM-00030">claim 30</claim-ref>, wherein the biostable material comprises polyurethane.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00033" num="00033" class="claim">
      <div class="claim-text">33. The implantable device according to <claim-ref idref="CLM-00030">claim 30</claim-ref>, wherein the biostable material comprises polyurethane and a hydrophilic polymer.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00034" num="00034" class="claim">
      <div class="claim-text">34. The implantable device according to <claim-ref idref="CLM-00030">claim 30</claim-ref>, wherein the biostable material comprises polyurethane and polyvinylpyrrolidone.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00035" num="00035" class="claim">
      <div class="claim-text">35. The implantable device according to <claim-ref idref="CLM-00030">claim 30</claim-ref>, wherein the biostable material comprises silicone and a hydrophilic component.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00036" num="00036" class="claim">
      <div class="claim-text">36. The implantable device according to <claim-ref idref="CLM-00030">claim 30</claim-ref>, wherein the first portion comprises silicone.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00037" num="00037" class="claim">
      <div class="claim-text">37. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the device comprises an implantable glucose sensor.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00038" num="00038" class="claim">
      <div class="claim-text">38. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the device comprises a cell transplantation device.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00039" num="00039" class="claim">
      <div class="claim-text">39. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the device comprises a drug delivery device.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00040" num="00040" class="claim">
      <div class="claim-text">40. The implantable device according to <claim-ref idref="CLM-00039">claim 39</claim-ref>, wherein the drug delivery device is selected from the group consisting of a pump, a microcapsule, and a macrocapsule.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00041" num="00041" class="claim">
      <div class="claim-text">41. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the device comprises an electrical signal measuring device.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00042" num="00042" class="claim">
      <div class="claim-text">42. The implantable device according to <claim-ref idref="CLM-00025">claim 25</claim-ref>, wherein the device comprises an electrical pulse delivering device.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00043" num="00043" class="claim">
      <div class="claim-text">43. An implantable glucose sensor, the sensor comprising:
<div class="claim-text">a porous silicone portion;</div>
<div class="claim-text">a non-porous skin, wherein the non-porous skin is adjacent to the porous silicone portion, and wherein the non-porous skin is permeable to glucose and is impermeable to cells or cell processes; and</div>
<div class="claim-text">a glucose measuring device.</div>
</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00044" num="00044" class="claim">
      <div class="claim-text">44. An implantable sensor, the sensor comprising:
<div class="claim-text">a porous membrane comprising silicone and configured to allow cells and cell processes to pass through;</div>
<div class="claim-text">a non-porous membrane that is permeable to analytes and impermeable to cells and cell processes; and</div>
<div class="claim-text">an analyte measuring device.</div>
</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00045" num="00045" class="claim">
      <div class="claim-text">45. An implantable glucose sensor, the sensor comprising:
<div class="claim-text">a fibrous domain that supports tissue ingrowth and configured to allow cells and cell processes to pass through;</div>
<div class="claim-text">a non-fibrous domain, wherein the non-fibrous domain is adjacent to the fibrous domain, and wherein the non-fibrous domain is permeable to analytes and is impermeable to cells or cell processes; and</div>
<div class="claim-text">a glucose measuring device.</div>
</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES34262862" lang="EN" load-source="patent-office" class="description">
    <heading>RELATED APPLICATION</heading> <p num="p-0002">This application is a continuation of application Ser. No. 09/916,386, filed Jul. 27, 2001.</p>
    <heading>FIELD OF THE INVENTION</heading> <p num="p-0003">The present invention relates generally to biointerface membranes that may be utilized with implantable devices such as devices for the detection of analyte concentrations in a biological sample, cell transplantation devices, drug delivery devices and electrical signal delivering or measuring devices. The present invention further relates to methods for determining analyte levels using implantable devices including these membranes. More particularly, the invention relates to novel biointerface membranes, to sensors and implantable devices including these membranes, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p num="p-0004">One of the most heavily investigated analyte sensing devices is an implantable glucose sensor for detecting glucose levels in patients with diabetes. Despite the increasing number of individuals diagnosed with diabetes and recent advances in the field of implantable glucose monitoring devices, currently used devices are unable to provide data safely and reliably for long periods of time (e.g., months or years) [See, e.g., Moatti-Sirat et al., Diabetologia 35:224-30 (1992)]. There are two commonly used types of implantable glucose sensing devices. These types are those which are implanted intravascularly and those implanted in tissue.</p>
    <p num="p-0005">With reference to devices that may be implanted in tissue, a disadvantage of these devices has been that they tend to lose their function after the first few days to weeks following implantation. At least one reason for this loss of function has been attributed to the fact that there is no direct contact with circulating blood to deliver sample to the tip of the probe of the implanted device. Because of these limitations, it has previously been difficult to obtain continuous and accurate glucose levels. However, this information is often extremely important to diabetic patients in ascertaining whether immediate corrective action is needed in order to adequately manage their disease.</p>
    <p num="p-0006">Some medical devices, including implanted analyte sensors, drug delivery devices and cell transplantation devices require transport of solutes across the device-tissue interface for proper function. These devices generally include a membrane, herein referred to as a cell-impermeable membrane that encases the device or a portion of the device to prevent access by host inflammatory or immune cells to sensitive regions of the device.</p>
    <p num="p-0007">A disadvantage of cell-impermeable membranes is that they often stimulate a local inflammatory response, called the foreign body response (FBR) that has long been recognized as limiting the function of implanted devices that require solute transport. Previous efforts to overcome this problem have been aimed at increasing local vascularization at the device-tissue interface with limited success.</p>
    <p num="p-0008">The FBR has been well described in the literature and is composed of three main layers, as illustrated in <figref idrefs="DRAWINGS">FIG. 1</figref>. The innermost FBR layer <b>40</b>, adjacent to the device, is composed generally of macrophages and foreign body giant cells <b>41</b> (herein referred to as the barrier cell layer). These cells form a monolayer <b>40</b> of closely opposed cells over the entire surface <b>48</b> <i>a </i>of a smooth or microporous (&lt;1.0 .mu·m) membrane <b>48</b>. The intermediate FBR layer <b>42</b> (herein referred to as the fibrous zone), lying distal to the first layer with respect to the device, is a wide zone (30-100 microns) composed primarily of fibroblasts <b>43</b> and fibrous matrix <b>44</b>. The outermost FBR layer <b>46</b> is loose connective granular tissue containing new blood vessels <b>45</b> (herein referred to as the vascular zone <b>46</b>). A consistent feature of the innermost layers <b>40</b> and <b>42</b> is that they are devoid of blood vessels. This has led to widely supported speculation that poor transport of molecules across the device-tissue interface <b>47</b> is due to a lack of vascularization near interface <b>47</b> (Scharp et al., World J. Surg. 8:221-229 (1984), Colton and Avgoustiniatos J. Biomech. Eng. 113:152-170 (1991)).</p>
    <p num="p-0009">Patents by Brauker et al. (U.S. Pat. No. 5,741,330), and Butler et al. (U.S. Pat. No. 5,913,998), describe inventions aimed at increasing the number of blood vessels adjacent to the implant membrane (Brauker et al.), and growing within (Butler et al.) the implant membrane at the device-tissue interface. The patent of Shults et al. (U.S. Pat. No. 6,001,067) describes membranes that induce angiogenesis at the device-tissue interface of implanted glucose sensors. <figref idrefs="DRAWINGS">FIG. 2</figref> illustrates a situation in which some blood vessels <b>45</b> are brought close to an implant membrane <b>48</b>, but the primary layer <b>40</b> of cells adherent to the cell-impermeable membrane blocks glucose. This phenomenon is described in further detail below.</p>
    <p num="p-0010">In the examples of Brauker et al. (supra), and Shults et al., bilayer membranes are described that have cell impermeable layers that are porous and adhesive to cells. Cells are able to enter into the interstices of these membranes, and form monolayers on the innermost layer, which is aimed at preventing cell access to the interior of the implanted device (cell impenetrable layers). Because the cell impenetrable layers are porous, cells are able to reach pseudopodia into the interstices of the membrane to adhere to and flatten on the membrane, as shown in <figref idrefs="DRAWINGS">FIGS. 1 and 2</figref>, thereby blocking transport of molecules across the membrane-tissue interface. The known art purports to increase the local vascularization in order to increase solute availability. However, the present studies show that once the monolayer of cells (barrier cell layer) is established adjacent to the membrane, increasing angiogenesis is not sufficient to increase transport of molecules such as glucose and oxygen across the device-tissue interface.</p>
    <p num="p-0011">One mechanism of inhibition of transport of solutes across the device-tissue interface that has not been previously discussed in the literature is the formation of a uniform barrier to analyte transport by cells that form the innermost layer of the foreign body capsule. This layer of cells forms a monolayer with closely opposed cells having tight cell-to-cell junctions. When this barrier cell layer forms, it is not substantially overcome by increased local vascularization. Regardless of the level of local vascularization, the barrier cell layer prevents the passage of molecules that cannot diffuse through the layer. Again, this is illustrated in <figref idrefs="DRAWINGS">FIG. 2</figref> where blood vessels <b>45</b> lie adjacent to the membrane but glucose transport is significantly reduced due to the impermeable nature of the barrier cell layer <b>40</b>. For example, both glucose and its phosphorylated form do not readily transit the cell membrane and consequently little glucose reaches the implant membrane through the barrier layer cells.</p>
    <p num="p-0012">It has been confirmed by the present inventors through histological examination of explanted sensors that the most likely mechanism for inhibition of molecular transport across the device-tissue interface is the barrier cell layer adjacent to the membrane. There is a strong correlation between desired device function and the lack of formation of a barrier cell layer at the device-tissue interface. In the present studies, devices that were observed histologically to have substantial barrier cell layers were functional only 41% of the time after 12 weeks in vivo. In contrast, devices that did not have significant barrier cell layers were functional 86% of the time after 12 weeks in vivo.</p>
    <p num="p-0013">Consequently, there is a need for a membrane that interferes with the formation of a barrier layer and protects the sensitive regions of the device from host inflammatory response.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p num="p-0014">The biointerface membranes of the present invention interfere with the formation of a monolayer of cells adjacent to the membrane, henceforth referred to herein as a barrier cell layer, which interferes with the transport of oxygen and glucose across a device-tissue interface.</p>
    <p num="p-0015">It is to be understood that various biointerface membrane architectures (e.g., variations of those described below) are contemplated by the present invention and are within the scope thereof.</p>
    <p num="p-0016">In one aspect of the present invention, a biointerface membrane for use with an implantable device is provided including; a first domain distal to the implantable device wherein the first domain supports tissue ingrowth and interferes with barrier-cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells and cell processes.</p>
    <p num="p-0017">In another aspect of the present invention, a biointerface membrane is provided including the properties of: promoting tissue ingrowth into; interfering with barrier cell formation on or within; resisting barrier-cell attachment to; and blocking cell penetration into the membrane.</p>
    <p num="p-0018">In yet another aspect, a sensor head for use in an implantable device is provided which includes a biointerface membrane of the present invention.</p>
    <p num="p-0019">In other aspects, a sensor for use in an implantable device that measures the concentration of an analyte in a biological fluid is provided including the biointerface membrane of the present invention.</p>
    <p num="p-0020">In still another aspect of the present invention, a device for measuring an analyte in a biological fluid is provided, the device including the biointerface membrane of the present invention, a housing which includes electronic circuitry, and at least one sensor as provided above operably connected to the electronic circuitry of the housing.</p>
    <p num="p-0021">The present invention further provides a method of monitoring analyte levels including the steps of: providing a host, and an implantable device as provided above; and implanting the device in the host. In one embodiment, the device is implanted subcutaneously.</p>
    <p num="p-0022">Further provided by the present invention is a method of measuring analyte in a biological fluid including the steps of: providing i) a host, and ii) a implantable device as provided above capable of accurate continuous analyte sensing; and implanting the device in the host. In one embodiment of the method, the device is implanted subcutaneously.</p>
    <p num="p-0023">In still another aspect of the present invention, an implantable drug delivery device is provided including a biointerface membrane as provided above. Preferably the implantable drug delivery device is a pump, a microcapsule or a macrocapsule.</p>
    <p num="p-0024">The present invention further provides a device for implantation of cells which includes a biointerface membrane as provided above.</p>
    <p num="p-0025">Also encompassed by the present invention is an electrical pulse delivering or measuring device, including a biointerface membrane according to that provided above.</p>
    <p num="p-0026">The biointerface membranes, devices including these membranes and methods of use of these membranes provided by the invention allow for long term protection of implanted cells or drugs, as well as continuous information regarding, for example, glucose levels of a host over extended periods of time. Because of these abilities, the biointerface membranes of the present invention can be extremely important in the management of transplant patients, diabetic patients and patients requiring frequent drug treatment.</p>
    <heading>DEFINITIONS</heading> <p num="p-0027">In order to facilitate an understanding of the present invention, a number of terms are defined below.</p>
    <p num="p-0028">The terms “biointerface membrane,” and the like refer to a permeable membrane that functions as a device-tissue interface comprised of two or more domains. Preferably, the biointerface membrane is composed of two domains. The first domain supports tissue ingrowth, interferes with barrier cell layer formation and includes an open cell configuration having cavities and a solid portion. The second domain is resistant to cellular attachment and impermeable to cells (e.g., macrophages). The biointerface membrane is made of biostable materials and may be constructed in layers, uniform or non-uniform gradients (i.e. anisotropic), or in a uniform or non-uniform cavity size configuration.</p>
    <p num="p-0029">The term “domain” refers to regions of the biointerface membrane that may be layers, uniform or non-uniform gradients (e.g. anisotropic) or provided as portions of the membrane.</p>
    <p num="p-0030">The term “barrier cell layer” refers to a cohesive monolayer of closely opposed cells (e.g. macrophages and foreign body giant cells) that may adhere to implanted membranes and interfere with the transport of molecules across the membrane.</p>
    <p num="p-0031">The phrase “distal to” refers to the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a device include a biointerface membrane having an cell disruptive domain and a cell impermeable domain. If the sensor is deemed to be the point of reference and the cell disruptive domain is positioned farther from the sensor, then that domain is distal to the sensor.</p>
    <p num="p-0032">The term “proximal to” refers to the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a device include a biointerface membrane having a cell disruptive domain and a cell impermeable domain. If the sensor is deemed to be the point of reference and the cell impermeable domain is positioned nearer to the sensor, then that domain is proximal to the sensor.</p>
    <p num="p-0033">The term “cell processes” and the like refers to pseudopodia of a cell.</p>
    <p num="p-0034">The term “solid portions” and the like refer to a material having a structure that may or may not have an open-cell configuration, but in either case prohibits whole cells from traveling through or residing within the material.</p>
    <p num="p-0035">The term “substantial number” refers to the number of linear dimensions within a domain (e.g. pores or solid portions) in which greater than 50 percent of all dimensions are of the specified size, preferably greater than 75 percent and, most preferably, greater than 90 percent of the dimensions have the specified size.</p>
    <p num="p-0036">The term “co-continuous” and the like refers to a solid portion wherein an unbroken curved line in three dimensions exists between any two points of the solid portion.</p>
    <p num="p-0037">The term “biostable” and the like refers to materials that are relatively resistant to degradation by processes that are encountered in vivo.</p>
    <p num="p-0038">The term “sensor” refers to the component or region of a device by which an analyte can be quantitated.</p>
    <p num="p-0039">The term “analyte” refers to a substance or chemical constituent in a biological fluid (e.g., blood or urine) that is intended to be analyzed. A preferred analyte for measurement by analyte detection devices including the biointerface membranes of the present invention is glucose.</p>
    <p num="p-0040">The terms “operably connected,” “operably linked,” and the like refer to one or more components being linked to another component(s) in a manner that allows transmission of signals between the components. For example, one or more electrodes may be used to detect the amount of analyte in a sample and convert that information into a signal; the signal may then be transmitted to an electronic circuit means. In this case, the electrode is “operably linked” to the electronic circuitry.</p>
    <p num="p-0041">The term “electronic circuitry” refers to the components of a device required to process biological information obtained from a host. In the case of an analyte measuring device, the biological information is obtained by a sensor regarding a particular analyte in a biological fluid, thereby providing data regarding the amount of that analyte in the fluid. U.S. Pat. Nos. 4,757,022, 5,497,772 and 4,787,398 describe suitable electronic circuit means that may be utilized with devices including the biointerface membrane of the present invention.</p>
    <p num="p-0042">The phrase “member for determining the amount of glucose in a biological sample” refers broadly to any mechanism (e.g., enzymatic or non-enzymatic) by which glucose can be quantitated. For example, some embodiments of the present invention utilize a membrane that contains glucose oxidase that catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate: Glucose+O.sub.2=Gluconate+H.sub.2O.sub.2-. Because for each glucose molecule metabolized, there is a proportional change in the co-reactant O.sub.2 and the product H.sub.2O.sub.2, one can monitor the current change in either the co-reactant or the product to determine glucose concentration.</p>
    <p num="p-0043">The term “host” refers generally to mammals, particularly humans.</p>
    <p num="p-0044">The term “accurately” means, for example, 90% of measured glucose values are within the “A” and “B” region of a standard Clarke error grid when the sensor measurements are compared to a standard reference measurement. It is understood that like any analytical device, calibration, calibration validation and recalibration are required for the most accurate operation of the device.</p>
    <p num="p-0045">The phrase “continuous glucose sensing” refers to the period in which monitoring of plasma glucose concentration is continuously performed, for example, about every 10 minutes.</p>
    <description-of-drawings> <heading>BRIEF DESCRIPTION OF THE DRAWINGS</heading> <p num="p-0046"> <figref idrefs="DRAWINGS">FIG. 1</figref> is an illustration of classical three-layered foreign body response to a synthetic membrane implanted under the skin.</p>
      <p num="p-0047"> <figref idrefs="DRAWINGS">FIG. 2</figref> is an illustration of a device having increased neovascularization within the intermediary layer of the foreign body response.</p>
      <p num="p-0048"> <figref idrefs="DRAWINGS">FIG. 3</figref> is an illustration of a membrane of the present invention including a barrier-cell disruptive domain composed of fibers and a cell impermeable domain.</p>
      <p num="p-0049"> <figref idrefs="DRAWINGS">FIG. 4</figref> is an illustration of a three dimensional section of the first domain showing the solid portions and cavities.</p>
      <p num="p-0050"> <figref idrefs="DRAWINGS">FIG. 5</figref> is an illustration of a cross-section of the first domain in <figref idrefs="DRAWINGS">FIG. 4</figref> showing solid portions and cavities.</p>
      <p num="p-0051"> <figref idrefs="DRAWINGS">FIG. 6A</figref> depicts a cross-sectional drawing of one embodiment of an implantable analyte measuring device for use in combination with a membrane according to the present invention.</p>
      <p num="p-0052"> <figref idrefs="DRAWINGS">FIG. 6B</figref> depicts a cross-sectional exploded view of the sensor head shown in <figref idrefs="DRAWINGS">FIG. 6A</figref>.</p>
      <p num="p-0053"> <figref idrefs="DRAWINGS">FIG. 6C</figref> depicts a cross-sectional exploded view of the electrode-membrane region set forth in <figref idrefs="DRAWINGS">FIG. 6B</figref>.</p>
      <p num="p-0054"> <figref idrefs="DRAWINGS">FIG. 7</figref> is a graphical representation of the number of functional sensors versus time (i.e. weeks) comparing control devices including only a cell-impermeable domain (“Control”), with devices including a cell-impermeable domain and a barrier-cell domain, in particular, wherein the barrier-cell disruptive domain includes non-woven fiber (“Non-Woven Fibers”) and wherein the barrier-cell disruptive domain includes porous silicone (“Porous Silicone”).</p>
    </description-of-drawings> <heading>DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT</heading> <p num="p-0055">The present invention relates generally to novel biointerface membranes, their uses with implantable devices and methods for determining analyte levels in a biological fluid. More particularly, the invention provides biointerface membranes that may be utilized with implantable devices and methods for monitoring and determining glucose levels in a biological fluid, a particularly important measurement for individuals having diabetes.</p>
    <p num="p-0056">Although the description that follows is primarily directed at glucose monitoring devices including the biointerface membranes of the present invention and methods for their use, these biointerface membranes are not limited to use in devices that measure or monitor glucose. Rather, these biointerface membranes may be applied to a variety of devices, including for example, those that detect and quantify other analytes present in biological fluids (including, but not limited to, cholesterol, amino acids and lactate), especially those analytes that are substrates for oxidase enzymes [see, e.g., U.S. Pat. No. 4,703,756 to Gough et al., hereby incorporated by reference] cell transplantation devices (U.S. Pat. Nos. 6,015,572, 5,964,745 and 6,083,523), drug delivery devices (U.S. Pat. Nos. 5,458,631, 5,820,589 and 5,972,369) and electrical delivery and/or measuring devices such as implantable pulse generation cardiac pacing devices (U.S. Pat. Nos. 6,157,860, 5,782,880 and 5,207,218), electrocardiogram device (U.S. Pat. Nos. 4,625,730 and 5,987,352) and electrical nerve stimulating devices (U.S. Pat. Nos. 6,175,767, 6,055,456 and 4,940,065).</p>
    <p num="p-0057">Implantable devices for detecting analyte concentrations in a biological system may utilize the biointerface membranes of the present invention to interfere with the formation of a barrier cell layer, thereby assuring that the sensor receives analyte concentrations representative of that in the vasculature. Drug delivery devices may utilize the biointerface membranes of the present invention to protect the drug housed within the device from host inflammatory or immune cells that might potentially damage or destroy the drug. In addition, the biointerface membrane prevents the formation of a barrier cell layer that might interfere with proper dispensing of drug from the device for treatment of the host. Correspondingly, cell transplantation devices may utilize the biointerface membranes of the present invention to protect the transplanted cells from attack by the host inflammatory or immune response cells while simultaneously allowing nutrients as well as other biologically active molecules needed by the cells for survival to diffuse through the membrane.</p>
    <p num="p-0058">The materials contemplated for use in preparing the biointerface membrane also eliminate or significantly delay biodegradation. This is particularly important for devices that continuously measure analyte concentrations. For example, in a glucose-measuring device, the electrode surfaces of the glucose sensor are in contact with (or operably connected with) a thin electrolyte phase, which in turn is covered by a membrane that contains an enzyme, e.g., glucose oxidase, and a polymer system. The biointerface membrane covers this enzyme membrane and serves, in part, to protect the sensor from external forces and factors that may result in biodegradation. By significantly delaying biodegradation at the sensor, accurate data may be collected over long periods of time (e.g. months to years). Correspondingly, biodegradation of the biointerface membrane of implantable cell transplantation devices and drug delivery devices could allow host inflammatory and immune cells to enter these devices, thereby compromising long-term function.</p>
    <p num="p-0059">Devices and probes that are implanted into subcutaneous tissue will almost always elicit a foreign body capsule (FBC) as part of the body's response to the introduction of a foreign material. Therefore, implantation of a glucose sensor results in an acute inflammatory reaction followed by building of fibrotic tissue. Ultimately, a mature FBC including primarily a vascular fibrous tissue forms around the device (Shanker and Greisler, Inflammation and Biomaterials in Greco R S, ed. Implantation Biology: The Host Response and Biomedical Devices, pp 68-80, CRC Press (1994)).</p>
    <p num="p-0060">In general, the formation of a FBC has precluded the collection of reliable, continuous information because it was previously believed to isolate the sensor of the implanted device in a capsule containing fluid that did not mimic the levels of analytes (e.g. glucose and oxygen) in the body's vasculature. Similarly, the composition of a FBC has prevented stabilization of the implanted device, contributing to motion artifact that also renders unreliable results. Thus, conventionally, it has been the practice of those skilled in the art to attempt to minimize FBC formation by, for example, using a short-lived needle geometry or sensor coatings to minimize the foreign body reaction.</p>
    <p num="p-0061">In contrast to conventionally known practice, the teachings of the present invention recognize that FBC formation is the dominant event surrounding long-term implantation of any sensor and must be managed to support rather than hinder or block sensor performance. It has been observed that during the early periods following implantation of an analyte-sensing device, particularly a glucose sensing device, glucose sensors function well. However, after a few days to two or more weeks of implantation, these device lose their function. For example, U.S. Pat. No. 5,791,344 and Gross et al. Performance Evaluation of the Minimed Continuous Monitoring System During Patient home Use”, Diabetes Technology and Therapuetics, Vol 2 Number 1, pp 49-56, 2000 have reported a glucose oxidase sensor (that has been approved for use in humans by the Food and Drug Administration) that functioned well for several days following implantation but loses function quickly after 3 days. We have observed similar device behavior with our implantable sensor. These results suggest that there is sufficient vascularization and, therefore, perfusion of oxygen and glucose to support the function of an implanted glucose sensor for the first few days following implantation. New blood vessel formation is clearly not needed for the function of a glucose oxidase mediated electrochemical sensor implanted in the subcutaneous tissue for at least several days after implantation.</p>
    <p num="p-0062">We have observed that this lack of sensor function after several days is most likely due to cells, such as polymorphonuclear cells and monocytes that migrate to the wound site during the first few days after implantation. These cells consume glucose and oxygen. If there is an overabundance of such cells, they may deplete the glucose and/or oxygen before it is able to reach the sensor enzyme layer, therefore reducing the sensitivity of the device or rendering it non-functional. After the first few days, further inhibition of device function may be due to cells that associate with the membrane of the device and physically block the transport of glucose into the device (i.e. barrier cells). Increased vascularization would not be expected to overcome barrier cell blockage. The present invention contemplates the use of particular biointerface membrane architectures that interfere with barrier cell layer formation on the membrane's surface. The present invention also contemplates the use of these membranes with a variety of implantable devices (e.g. analyte measuring devices, particularly glucose measuring devices, cell transplantation devices, drug delivery devices and electrical signal delivery and measuring devices).</p>
    <p num="p-0063">The sensor interface region refers to the region of a monitoring device responsible for the detection of a particular analyte. For example, in some embodiments of a glucose-monitoring device, the sensor interface refers to that region where a biological sample contacts (directly or after passage through one or more membranes or layers) an enzyme (e.g., glucose oxidase). The sensor interface region may include a biointerface membrane according to the present invention having different domains and/or layers that can cover and protect an underlying enzyme membrane and the electrodes of an implantable analyte-measuring device. In general, the biointerface membranes of the present invention prevent direct contact of the biological fluid sample with the sensor. The membranes only permit selected substances (e.g., analytes) of the fluid to pass therethrough for reaction in the immobilized enzyme domain. The biointerface membranes of the present invention are biostable and prevent barrier cell formation. The characteristics of this biointerface membrane are now discussed in more detail.</p>
    <p num="h-0008">I. Biointerface Membrane</p>
    <p num="p-0064">The biointerface membrane is constructed of two or more domains. Referring now to <figref idrefs="DRAWINGS">FIG. 3</figref>, preferably, the membrane includes a cell impermeable domain <b>50</b> proximal to an implantable device, also referred to as the second domain; and a cell disruptive domain, which in the embodiment illustrated includes non-woven fibers <b>49</b> distal to an implantable device, also referred to as the first domain.</p>
    <p num="p-0065">A. Barrier-Cell Disruptive (First) Domain</p>
    <p num="p-0066">As described above, the outermost domain of the inventive membrane includes a material that supports tissue ingrowth. The barrier-cell disruptive domain may be composed of an open-cell configuration having cavities and solid portions. For example, <figref idrefs="DRAWINGS">FIG. 4</figref> is an illustration of a three dimensional section <b>60</b> of a barrier-cell disruptive domain having solid portions <b>62</b> and cavities <b>64</b>. Cells may enter into the cavities, however, they can not travel through or wholly exist within the solid portions. The cavities allow most substances to pass through, including, e.g., macrophages.</p>
    <p num="p-0067">The open-cell configuration yields a co-continuous solid domain that contains greater than one cavity in three dimensions substantially throughout the entirety of the membrane. In addition, the cavities and cavity interconnections may be formed in layers having different cavity dimensions.</p>
    <p num="p-0068">In order to better describe the dimensions of cavities and solid portions, a two dimensional plane <b>66</b> cut through the barrier-cell disruptive domain can be utilized (<figref idrefs="DRAWINGS">FIG. 5</figref>). A dimension across a cavity <b>64</b> or solid portion <b>62</b> can be described as a linear line. The length of the linear line is the distance between two points lying at the interface of the cavity and solid portion. In this way, a substantial number of the cavities are not less than 20 microns in the shortest dimension and not more than 1000 microns in the longest dimension. Preferably, a substantial number of the cavities are not less than 25 microns in the shortest dimension and not more than 500 microns in the longest dimension.</p>
    <p num="p-0069">Furthermore, the solid portion has not less than 5 microns in a substantial number of the shortest dimensions and not more than 2000 microns in a substantial number of the longest dimensions. Preferably, the solid portion is not less than 10 microns in a substantial number of the shortest dimensions and not more than 1000 microns in a substantial number of the longest dimensions and, most preferably, not less than 10 microns in a substantial number of the shortest dimensions and not more than 400 microns in a substantial number of the longest dimensions.</p>
    <p num="p-0070">The solid portion may be comprised of polytetrafluoroethylene or polyethyleneco-tetrafluoroethylene. Preferably, the solid portion includes polyurethanes or block copolymers and, most preferably, is comprised of silicone.</p>
    <p num="p-0071">In desired embodiments, the solid portion is composed of porous silicone or non-woven fibers. Non-woven fibers are preferably made from polyester or polypropylene. For example, <figref idrefs="DRAWINGS">FIG. 3</figref> illustrates how the non-woven fibers <b>49</b> serve to disrupt the continuity of cells, such that they are not able to form a classical foreign body response. All the cell types that are involved in the formation of a FBR may be present. However, they are unable to form an ordered closely opposed cellular monolayer parallel to the surface of the device as in a typical foreign body response to a smooth surface. In this example, the 10-micron dimension provides a suitable surface for foreign body giant cells, but the fibers are in such proximity to allow and foster in growth of blood vessels <b>45</b> and vascularize the biointerface region (<figref idrefs="DRAWINGS">FIG. 3</figref>). Devices with smaller fibers have been used in previous inventions, but such membranes are prone to delamination due to the forces applied by cells in the interstices of the membrane. After delamination, cells are able to form barrier layers on the smooth or microporous surface of the bioprotective layer if it is adhesive to cells or has pores of sufficient size for physical penetration of cell processes, but not of whole cells.</p>
    <p num="p-0072">When non-woven fibers are utilized as the solid portion of the present invention, the non-woven fibers may be greater than 5 microns in the shortest dimension. Preferably, the non-woven fibers are about 10 microns in the shortest dimension and, most preferably, the non-woven fibers are greater than or equal to 10 microns in the shortest dimension.</p>
    <p num="p-0073">The non-woven fibers may be constructed of polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones, and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers (block copolymers are discussed in U.S. Pat. Nos. 4,803,243 and 4,686,044, hereby incorporated by reference). Preferably, the non-woven fibers are comprised of polyolefins or polyester or polycarbonates or polytetrafluoroethylene. The thickness of the cell disruptive domain is not less than about 20 microns and not more than about 2000 microns.</p>
    <p num="p-0074">B. Cell Impermeable (Second) Domain</p>
    <p num="p-0075">The inflammatory response that initiates and sustains a FBC is associated with disadvantages in the practice of sensing analytes. Inflammation is associated with invasion of inflammatory response cells (e.g. macrophages) which have the ability to overgrow at the interface forming barrier cell layers which may block transport across the biointerface membrane. These inflammatory cells may also biodegrade many artificial biomaterials (some of which were, until recently, considered nonbiodegradable). When activated by a foreign body, tissue macrophages degranulate, releasing from their cytoplasmic myeloperoxidase system hypochlorite (bleach) and other oxidative species. Hypochlorite and other oxidative species are known to break down a variety of polymers. However, polycarbonate based polyurethanes are believed to be resistant to the effects of these oxidative species and have been termed biodurable. In addition, because hypochlorite and other oxidizing species are short-lived chemical species in vivo, biodegradation will not occur if macrophages are kept a sufficient distance from the enzyme active membrane.</p>
    <p num="p-0076">The present invention contemplates the use of cell impermeable biomaterials of a few microns thickness or more (i.e., a cell impermeable domain) in most of its membrane architectures. Desirably, the thickness of the cell impermeable domain is not less than about 10 microns and not more than about 100 microns. This domain of the biointerface membrane is permeable to oxygen and may or may not be permeable to glucose and is constructed of biodurable materials (e.g. for period of several years in vivo) that are impermeable by host cells (e.g. macrophages) such as, for example, polymer blends of polycarbonate based polyurethane and PVP.</p>
    <p num="p-0077">The innermost domain of the inventive membrane is non-adhesive for cells (i.e. the cell impermeable domain), which is in contrast to the inventions of Brauker et al. (supra), and Shults et al. (supra). In both of these previous patents, examples are provided in which the cellimpenetrable membrane (Brauker et al.) or biointerface membrane (Shults et al.) are derived from a membrane known as Biopore.™. as a cell culture support sold by Millipore (Bedford, Mass.). In the presence of certain extracellular matrix molecules, and also in vivo, many cell types are able to strongly adhere to this membrane making it incapable of serving as a non-adhesive domain. Further, since they allow adherence of cells to the innermost layer of the membrane they promote barrier cell layer formation that decreases the membranes ability to transport molecules across the device-tissue interface. Moreover, when these cells multiply, they ultimately cause pressure between the membrane layers resulting in delamination of the layers and catastrophic failure of the membrane.</p>
    <p num="p-0078">As described above, in one embodiment of the inventive membrane, the second domain is resistant to cellular attachment and is impermeable to cells and preferably composed of a biostable material. The second domain may be formed from materials such as those previously listed for the first domain and as copolymers or blends with hydrophilic polymers such as polyvinylpyrrolidone (PVP), polyhydroxyethyl methacrylate, polyvinylalcohol, polyacrylic acid, polyethers, such as polyethylene glycol, and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers (block copolymers are discussed in U.S. Pat. Nos. 4,803,243 and 4,686,044, hereby incorporated by reference).</p>
    <p num="p-0079">Preferably, the second domain is comprised of a polyurethane and a hydrophilic polymer. Desirably, the hydrophilic polymer is polyvinylpyrrolidone. In one embodiment of this aspect of the invention, the second domain is polyurethane comprising not less than 5 weight percent polyvinylpyrrolidone and not more than 45 weight percent polyvinylpyrrolidone. Preferably, the second domain comprises not less than 20 weight percent polyvinylpyrrolidone and not more than 35 weight percent polyvinylpyrrolidone and, most preferably, polyurethane comprising about 27 weight percent polyvinylpyrrolidone.</p>
    <p num="p-0080">As described above, in one desired embodiment the cell impermeable domain is comprised of a polymer blend comprised of a non-biodegradable polyurethane comprising polyvinylpyrrolidone. This prevents adhesion of cells in vitro and in vivo and allows many molecules to freely diffuse through the membrane. However, this domain prevents cell entry or contact with device elements underlying the membrane, and prevents the adherence of cells, and thereby prevents the formation of a barrier cell layer.</p>
    <p num="h-0009">II. Implantable Glucose Monitoring Devices Using the Biointerface Membranes of the Present Invention</p>
    <p num="p-0081">The present invention contemplates the use of unique membrane architectures around the sensor interface of an implantable device. However, it should be pointed out that the present invention does not require a device including particular electronic components (e.g., electrodes, circuitry, etc). Indeed, the teachings of the present invention can be used with virtually any monitoring device suitable for implantation (or subject to modification allowing implantation); suitable devices include, analyte measuring devices, cell transplantation devices, drug delivery devices, electrical signal delivery and measurement devices and other devices such as those described in U.S. Pat. Nos. 4,703,756 and 4,994,167 to Shults et al.; U.S. Pat. No. 4,703,756 to Gough et al., and U.S. Pat. No. 4,431,004 to Bessman et al.; the contents of each being hereby incorporated by reference, and Bindra et al., Anal. Chem. 63:1692-96 (1991).</p>
    <p num="p-0082">We refer now to <figref idrefs="DRAWINGS">FIG. 6A</figref>, which shows a preferred embodiment of an analyte measuring device for use in combination with a membrane according to the present invention. In this embodiment, a ceramic body <b>1</b> and ceramic head <b>10</b> houses the sensor electronics that include a circuit board <b>2</b>, a microprocessor <b>3</b>, a battery <b>4</b>, and an antenna <b>5</b>. Furthermore, the ceramic body <b>1</b> and head <b>10</b> possess a matching taper joint <b>6</b> that is sealed with epoxy. The electrodes are subsequently connected to the circuit board via a socket <b>8</b>.</p>
    <p num="p-0083">As indicated in detail in <figref idrefs="DRAWINGS">FIG. 6B</figref>, three electrodes protrude through the ceramic head <b>10</b>, a platinum working electrode <b>21</b>, a platinum counter electrode <b>22</b> and a silver/silver chloride reference electrode <b>20</b>. Each of these is hermetically brazed <b>26</b> to the ceramic head <b>10</b> and further affixed with epoxy <b>28</b>. The sensing region <b>24</b> is covered with the sensing membrane described below and the ceramic head <b>10</b> contains a groove <b>29</b> so that the membrane may be affixed into place with an o-ring.</p>
    <p num="p-0084"> <figref idrefs="DRAWINGS">FIG. 6C</figref> depicts a cross-sectional exploded view of the electrode-membrane region <b>24</b> set forth in <figref idrefs="DRAWINGS">FIG. 6B</figref> detailing the sensor tip and the functional membrane layers. As depicted in <figref idrefs="DRAWINGS">FIG. 6C</figref>, the electrode-membrane region includes the inventive biointerface membrane <b>33</b> and a sensing membrane <b>32</b>. The top ends of the electrodes are in contact with the electrolyte phase <b>30</b>, a free-flowing fluid phase. The electrolyte phase is covered by the sensing membrane <b>32</b> that includes an enzyme, e.g., glucose oxidase. In turn, the inventive interface membrane <b>33</b> covers the enzyme membrane <b>32</b> and serves, in part, to protect the sensor from external forces that may result in environmental stress cracking of the sensing membrane <b>32</b>.</p>
    <p num="h-0010">III. Experimental</p>
    <p num="p-0085">The following examples serve to illustrate certain preferred embodiments and aspects of the present invention and are not to be construed as limiting the scope thereof</p>
    <p num="p-0086">In the preceding description and the experimental disclosure which follows, the following abbreviations apply: Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) .mu·M (micromolar); N (Normal); mol (moles); mmol (millimoles); .mu·mol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); .mu·g (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); .mu·L (microliters); cm (centimeters); mm (millimeters); .mu·m (micrometers); nm (nanometers); h and hr (hours); min. (minutes); s and sec. (seconds); .degree. C. (degrees Centigrade); Astor Wax (Titusville, Pa.); BASF Wyandotte Corporation (Parsippany, N.J.); Data Sciences, Inc. (St. Paul, Minn.); Douglas Hansen Co., Inc. (Minneapolis, Minn.); DuPont (DuPont Co., Wilmington, Del.); Exxon Chemical (Houston, Tex.); GAF Corporation (New York, N.Y.); Markwell Medical (Racine, Wis.); Meadox Medical, Inc. (Oakland, N.J.); Mobay (Mobay Corporation, Pittsburgh, Pa.); Sandoz (East Hanover, N.J.); and Union Carbide (Union Carbide Corporation; Chicago, Ill.).</p>
    <heading>Example 1</heading> <heading>Preparation of Biointerface Membrane with Non-Woven Fibers</heading> <p num="p-0087">The barrier-cell disruptive domain may be prepared from a non-woven polyester fiber filtration membrane. The cell-impermeable domain may then be coated on this domain layer. The cell-impermeable domain was prepared by placing approximately 706 gm of dimethylacetamide (DMAC) into a 3 L stainless steel bowl to which a polycarbonateurethane solution (1325 g, Chronoflex AR 25% solids in DMAC and a viscosity of 5100 cp) and polyvinylpyrrolidone (125 g, Plasdone K-90D) were added. The bowl was then fitted to a planetary mixer with a paddle type blade and the contents were stirred for 1 hour at room temperature. This solution was then coated on the barrier-cell disruptive domain by knife-edge drawn at a gap of 0.006″ and dried at 60.degree. C. for 24 hours. The membrane is then mechanically secured to the sensing device by an O-ring.</p>
    <heading>Example 2</heading> <heading>Preparation of Biointerface Membrane with Porous Silicone</heading> <p num="p-0088">The barrier-cell disruptive domain can be comprised of a porous silicone sheet. The porous silicone was purchased from Seare Biomatrix Systems, Inc. The cell-impermeable domain was prepared by placing approximately 706 gm of dimethylacetamide (DMAC) into a 3 L stainless steel bowl to which a polycarbonateurethane solution (1,325 gm, Chronoflex AR 25% solids in DMAC and a viscosity of 5100 cp) and polyvinylpyrrolidone (125 gm, Plasdone K-90D) were added. The bowl was then fitted to a planetary mixer with a paddle type blade and the contents were stirred for 1 hour at room temperature. The cell-impermeable domain coating solution was then coated onto a PET release liner (Douglas Hansen Co.) using a knife over roll set at a 0.012″ gap. This film was then dried at 305.degree. F. The final film was approximately 0.0015″ thick. The biointerface membrane was prepared by pressing the porous silicone onto the cast cell-impermeable domain. The membrane is then mechanically secured to the sensing device by an O-ring.</p>
    <heading>Example 3</heading> <heading>Test Method for Glucose Measuring Device Function</heading> <p num="p-0089">In vivo sensor function was determined by correlating the sensor output to blood glucose values derived from an external blood glucose meter. We have found that non-diabetic dogs do not experience rapid blood glucose changes, even after ingestion of a high sugar meal. Thus, a 10% dextrose solution was infused into the sensor-implanted dog. A second catheter is placed in the opposite leg for the purpose of blood collection. The implanted sensor was programmed to transmit at 30-second intervals using a pulsed electromagnet. A dextrose solution was infused at a rate of 9.3 ml/minute for the first 25 minutes, 3.5 ml/minute for the next 20 minutes, 1.5 ml/minute for the next 20 minutes, and then the infusion pump was powered off Blood glucose values were measured in duplicate every five minutes on a blood glucose meter (LXN Inc., San Diego, Calif.) for the duration of the study. A computer collected the sensor output. The data was then compiled and graphed in a spreadsheet, time aligned, and time shifted until an optimal R-squared value was achieved. The R-squared value reflects how well the sensor tracks with the blood glucose values.</p>
    <heading>Example 4</heading> <heading>In Vivo Evaluation of Glucose Measuring Devices Including the Biointerface Membranes of the Present Invention</heading> <p num="p-0090">To test the importance of a cell-disruptive membrane, implantable glucose sensors comprising the biointerface membranes of the present invention were implanted into dogs in the subcutaneous tissues and monitored for glucose response on a weekly basis. Control devices comprising only a cell-impermeable domain (“Control”) were compared with devices comprising a cell-impermeable domain and a barrier-cell disruptive domain, in particular, wherein the barrier-cell disruptive domain was either a non-woven fiber (“Non-Woven Fibers”) or porous silicone (“Porous Silicone”).</p>
    <p num="p-0091">Four devices from each condition were implanted subcutaneously in the ventral abdomen of normal dogs. On a weekly basis, the dogs were infused with glucose as described in Example 3 in order to increase their blood glucose levels from about 120 mg/dl to about 300 mg/dl. Blood glucose values were determined with a LXN blood glucose meter at 5-minute intervals. Sensor values were transmitted at 0.5-minute intervals. Regression analysis was done between blood glucose values and the nearest sensor value within one minute. Devices that yielded an R-squared value greater than 0.5 were considered functional. <figref idrefs="DRAWINGS">FIG. 7</figref> shows, for each condition, the number of functional devices over the 12-week period of the study. Both test devices performed better than the control devices over the first 9 weeks of the study. All of the porous silicone devices were functional by week 9. Two of 4 polypropylene fiber devices were functional by week 2, and 3 of 4 were functional on week 12. In contrast, none of the control devices were functional until week 10, after which 2 were functional for the remaining 3 weeks. These data clearly show that the use of a cell-disruptive layer in combination with a cell-impermeable layer improves the function of implantable glucose sensors.</p>
    <p num="p-0092">The description and experimental materials presented above are intended to be illustrative of the present invention while not limiting the scope thereof It will be apparent to those skilled in the art that variations and modifications can be made without departing from the spirit and scope of the present invention.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3775182">US3775182</a></td><td class="patent-data-table-td patent-date-value">Feb 25, 1972</td><td class="patent-data-table-td patent-date-value">Nov 27, 1973</td><td class="patent-data-table-td ">Du Pont</td><td class="patent-data-table-td ">Tubular electrochemical cell with coiled electrodes and compressed central spindle</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3898984">US3898984</a></td><td class="patent-data-table-td patent-date-value">Feb 4, 1974</td><td class="patent-data-table-td patent-date-value">Aug 12, 1975</td><td class="patent-data-table-td ">Us Navy</td><td class="patent-data-table-td ">Ambulatory patient monitoring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3929971">US3929971</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 1973</td><td class="patent-data-table-td patent-date-value">Dec 30, 1975</td><td class="patent-data-table-td ">Research Corp</td><td class="patent-data-table-td ">Porous biomaterials and method of making same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3943918">US3943918</a></td><td class="patent-data-table-td patent-date-value">Dec 2, 1971</td><td class="patent-data-table-td patent-date-value">Mar 16, 1976</td><td class="patent-data-table-td ">Tel-Pac, Inc.</td><td class="patent-data-table-td ">Disposable physiological telemetric device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3964974">US3964974</a></td><td class="patent-data-table-td patent-date-value">Sep 10, 1973</td><td class="patent-data-table-td patent-date-value">Jun 22, 1976</td><td class="patent-data-table-td ">Merck Patent Gesellschaft Mit Beschrankter Haftung</td><td class="patent-data-table-td ">Glucose dehydrogenase, pyridine coenzyme, mutarotase</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3966580">US3966580</a></td><td class="patent-data-table-td patent-date-value">Sep 16, 1974</td><td class="patent-data-table-td patent-date-value">Jun 29, 1976</td><td class="patent-data-table-td ">The University Of Utah</td><td class="patent-data-table-td ">Novel protein-immobilizing hydrophobic polymeric membrane, process for producing same and apparatus employing same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3979274">US3979274</a></td><td class="patent-data-table-td patent-date-value">Sep 24, 1975</td><td class="patent-data-table-td patent-date-value">Sep 7, 1976</td><td class="patent-data-table-td ">The Yellow Springs Instrument Company, Inc.</td><td class="patent-data-table-td ">Membrane for enzyme electrodes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4024312">US4024312</a></td><td class="patent-data-table-td patent-date-value">Jun 23, 1976</td><td class="patent-data-table-td patent-date-value">May 17, 1977</td><td class="patent-data-table-td ">Johnson &amp; Johnson</td><td class="patent-data-table-td ">Pressure-sensitive adhesive tape having extensible and elastic backing composed of a block copolymer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4040908">US4040908</a></td><td class="patent-data-table-td patent-date-value">Mar 12, 1976</td><td class="patent-data-table-td patent-date-value">Aug 9, 1977</td><td class="patent-data-table-td ">Children&#39;s Hospital Medical Center</td><td class="patent-data-table-td ">Polarographic analysis of cholesterol and other macromolecular substances</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4073713">US4073713</a></td><td class="patent-data-table-td patent-date-value">Jul 26, 1976</td><td class="patent-data-table-td patent-date-value">Feb 14, 1978</td><td class="patent-data-table-td ">The Yellow Springs Instrument Company, Inc.</td><td class="patent-data-table-td ">Membrane for enzyme electrodes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4076656">US4076656</a></td><td class="patent-data-table-td patent-date-value">Jul 20, 1973</td><td class="patent-data-table-td patent-date-value">Feb 28, 1978</td><td class="patent-data-table-td ">Debell &amp; Richardson, Inc.</td><td class="patent-data-table-td ">Channel-forming liquid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4172770">US4172770</a></td><td class="patent-data-table-td patent-date-value">Mar 27, 1978</td><td class="patent-data-table-td patent-date-value">Oct 30, 1979</td><td class="patent-data-table-td ">Technicon Instruments Corporation</td><td class="patent-data-table-td ">Flow-through electrochemical system analytical method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4197840">US4197840</a></td><td class="patent-data-table-td patent-date-value">Sep 29, 1976</td><td class="patent-data-table-td patent-date-value">Apr 15, 1980</td><td class="patent-data-table-td ">Bbc Brown Boveri &amp; Company, Limited</td><td class="patent-data-table-td ">Permanent magnet device for implantation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4215703">US4215703</a></td><td class="patent-data-table-td patent-date-value">Aug 29, 1978</td><td class="patent-data-table-td patent-date-value">Aug 5, 1980</td><td class="patent-data-table-td ">Willson James K V</td><td class="patent-data-table-td ">Variable stiffness guide wire</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4225410">US4225410</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 1978</td><td class="patent-data-table-td patent-date-value">Sep 30, 1980</td><td class="patent-data-table-td ">Technicon Instruments Corporation</td><td class="patent-data-table-td ">Integrated array of electrochemical sensors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4240889">US4240889</a></td><td class="patent-data-table-td patent-date-value">Jan 24, 1979</td><td class="patent-data-table-td patent-date-value">Dec 23, 1980</td><td class="patent-data-table-td ">Toyo Boseki Kabushiki Kaisha</td><td class="patent-data-table-td ">Two layer, permselective, for detecting hydrogen peroxide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4253469">US4253469</a></td><td class="patent-data-table-td patent-date-value">Apr 20, 1979</td><td class="patent-data-table-td patent-date-value">Mar 3, 1981</td><td class="patent-data-table-td ">The Narda Microwave Corporation</td><td class="patent-data-table-td ">Implantable temperature probe</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4255500">US4255500</a></td><td class="patent-data-table-td patent-date-value">Mar 29, 1979</td><td class="patent-data-table-td patent-date-value">Mar 10, 1981</td><td class="patent-data-table-td ">General Electric Company</td><td class="patent-data-table-td ">Vibration resistant electrochemical cell having deformed casing and method of making same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4259540">US4259540</a></td><td class="patent-data-table-td patent-date-value">Apr 20, 1979</td><td class="patent-data-table-td patent-date-value">Mar 31, 1981</td><td class="patent-data-table-td ">Bell Telephone Laboratories, Incorporated</td><td class="patent-data-table-td ">Filled cables</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4260725">US4260725</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 10, 1979</td><td class="patent-data-table-td patent-date-value">Apr 7, 1981</td><td class="patent-data-table-td ">Bausch &amp; Lomb Incorporated</td><td class="patent-data-table-td ">Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4353888">US4353888</a></td><td class="patent-data-table-td patent-date-value">Dec 23, 1980</td><td class="patent-data-table-td patent-date-value">Oct 12, 1982</td><td class="patent-data-table-td ">Sefton Michael V</td><td class="patent-data-table-td ">In semipermeable polymeric membrane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4374013">US4374013</a></td><td class="patent-data-table-td patent-date-value">Mar 3, 1981</td><td class="patent-data-table-td patent-date-value">Feb 15, 1983</td><td class="patent-data-table-td ">Enfors Sven Olof</td><td class="patent-data-table-td ">Oxygen stabilized enzyme electrode</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4388166">US4388166</a></td><td class="patent-data-table-td patent-date-value">May 15, 1982</td><td class="patent-data-table-td patent-date-value">Jun 14, 1983</td><td class="patent-data-table-td ">Tokyo Shibaura Denki Kabushiki Kaisha</td><td class="patent-data-table-td ">Immobilized enzyme such as glucose oxidase on a substrate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4403984">US4403984</a></td><td class="patent-data-table-td patent-date-value">Dec 22, 1980</td><td class="patent-data-table-td patent-date-value">Sep 13, 1983</td><td class="patent-data-table-td ">Biotek, Inc.</td><td class="patent-data-table-td ">System for demand-based adminstration of insulin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4415666">US4415666</a></td><td class="patent-data-table-td patent-date-value">Nov 5, 1981</td><td class="patent-data-table-td patent-date-value">Nov 15, 1983</td><td class="patent-data-table-td ">Miles Laboratories, Inc.</td><td class="patent-data-table-td ">Enzyme electrode membrane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4418148">US4418148</a></td><td class="patent-data-table-td patent-date-value">Nov 5, 1981</td><td class="patent-data-table-td patent-date-value">Nov 29, 1983</td><td class="patent-data-table-td ">Miles Laboratories, Inc.</td><td class="patent-data-table-td ">Encapsulated enzymes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4431004">US4431004</a></td><td class="patent-data-table-td patent-date-value">Oct 27, 1981</td><td class="patent-data-table-td patent-date-value">Feb 14, 1984</td><td class="patent-data-table-td ">Bessman Samuel P</td><td class="patent-data-table-td ">Implantable glucose sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4436094">US4436094</a></td><td class="patent-data-table-td patent-date-value">Jan 27, 1982</td><td class="patent-data-table-td patent-date-value">Mar 13, 1984</td><td class="patent-data-table-td ">Evreka, Inc.</td><td class="patent-data-table-td ">Monitor for continuous in vivo measurement of glucose concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4442841">US4442841</a></td><td class="patent-data-table-td patent-date-value">Apr 30, 1981</td><td class="patent-data-table-td patent-date-value">Apr 17, 1984</td><td class="patent-data-table-td ">Mitsubishi Rayon Company Limited</td><td class="patent-data-table-td ">Porosity, membranes, metal, dielectrics, wires</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4453537">US4453537</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 1981</td><td class="patent-data-table-td patent-date-value">Jun 12, 1984</td><td class="patent-data-table-td ">Spitzer Daniel E</td><td class="patent-data-table-td ">Apparatus for powering a body implant device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4477314">US4477314</a></td><td class="patent-data-table-td patent-date-value">Jul 20, 1983</td><td class="patent-data-table-td patent-date-value">Oct 16, 1984</td><td class="patent-data-table-td ">Siemens Aktiengesellschaft</td><td class="patent-data-table-td ">Method for determining sugar concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4484987">US4484987</a></td><td class="patent-data-table-td patent-date-value">May 19, 1983</td><td class="patent-data-table-td patent-date-value">Nov 27, 1984</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Method and membrane applicable to implantable sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4494950">US4494950</a></td><td class="patent-data-table-td patent-date-value">Jan 19, 1982</td><td class="patent-data-table-td patent-date-value">Jan 22, 1985</td><td class="patent-data-table-td ">The Johns Hopkins University</td><td class="patent-data-table-td ">Plural module medication delivery system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4506680">US4506680</a></td><td class="patent-data-table-td patent-date-value">Mar 17, 1983</td><td class="patent-data-table-td patent-date-value">Mar 26, 1985</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Drug dispensing body implantable lead</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4534355">US4534355</a></td><td class="patent-data-table-td patent-date-value">Oct 13, 1981</td><td class="patent-data-table-td patent-date-value">Aug 13, 1985</td><td class="patent-data-table-td ">Smith And Nephew Associated Companies Inc.</td><td class="patent-data-table-td ">Monitoring oxygen levels in blood gas using a polyetherurethane copolymer sheath</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4554927">US4554927</a></td><td class="patent-data-table-td patent-date-value">Aug 30, 1983</td><td class="patent-data-table-td patent-date-value">Nov 26, 1985</td><td class="patent-data-table-td ">Thermometrics Inc.</td><td class="patent-data-table-td ">Pressure and temperature sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4571292">US4571292</a></td><td class="patent-data-table-td patent-date-value">Aug 12, 1982</td><td class="patent-data-table-td patent-date-value">Feb 18, 1986</td><td class="patent-data-table-td ">Case Western Reserve University</td><td class="patent-data-table-td ">Apparatus for electrochemical measurements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4577642">US4577642</a></td><td class="patent-data-table-td patent-date-value">Feb 27, 1985</td><td class="patent-data-table-td patent-date-value">Mar 25, 1986</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Drug dispensing body implantable lead employing molecular sieves and methods of fabrication</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4650547">US4650547</a></td><td class="patent-data-table-td patent-date-value">Dec 20, 1985</td><td class="patent-data-table-td patent-date-value">Mar 17, 1987</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Method and membrane applicable to implantable sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4663824">US4663824</a></td><td class="patent-data-table-td patent-date-value">Jul 5, 1984</td><td class="patent-data-table-td patent-date-value">May 12, 1987</td><td class="patent-data-table-td ">Matsushita Electric Industrial Co., Ltd.</td><td class="patent-data-table-td ">Aluminum electrolytic capacitor and a manufacturing method therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4671288">US4671288</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 1985</td><td class="patent-data-table-td patent-date-value">Jun 9, 1987</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Electrochemical cell sensor for continuous short-term use in tissues and blood</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4680268">US4680268</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 18, 1985</td><td class="patent-data-table-td patent-date-value">Jul 14, 1987</td><td class="patent-data-table-td ">Children&#39;s Hospital Medical Center</td><td class="patent-data-table-td ">Implantable gas-containing biosensor and method for measuring an analyte such as glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4686044">US4686044</a></td><td class="patent-data-table-td patent-date-value">Dec 9, 1985</td><td class="patent-data-table-td patent-date-value">Aug 11, 1987</td><td class="patent-data-table-td ">Akzo Nv</td><td class="patent-data-table-td ">Polycarbonate-polyether-copolymer membrane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4689309">US4689309</a></td><td class="patent-data-table-td patent-date-value">Sep 30, 1985</td><td class="patent-data-table-td patent-date-value">Aug 25, 1987</td><td class="patent-data-table-td ">Miles Laboratories, Inc.</td><td class="patent-data-table-td ">Test device, method of manufacturing same and method of determining a component in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4702732">US4702732</a></td><td class="patent-data-table-td patent-date-value">Nov 21, 1986</td><td class="patent-data-table-td patent-date-value">Oct 27, 1987</td><td class="patent-data-table-td ">Trustees Of Boston University</td><td class="patent-data-table-td ">Conveying energy to polymer matrix and active ligand</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4703756">US4703756</a></td><td class="patent-data-table-td patent-date-value">May 6, 1986</td><td class="patent-data-table-td patent-date-value">Nov 3, 1987</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Differential measurement, oxygen sensors, glucose oxidase</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4711251">US4711251</a></td><td class="patent-data-table-td patent-date-value">Mar 31, 1983</td><td class="patent-data-table-td patent-date-value">Dec 8, 1987</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Drug dispensing electrode, storage means</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4721677">US4721677</a></td><td class="patent-data-table-td patent-date-value">May 7, 1987</td><td class="patent-data-table-td patent-date-value">Jan 26, 1988</td><td class="patent-data-table-td ">Children&#39;s Hospital Medical Center</td><td class="patent-data-table-td ">Implantable gas-containing biosensor and method for measuring an analyte such as glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4731726">US4731726</a></td><td class="patent-data-table-td patent-date-value">May 19, 1986</td><td class="patent-data-table-td patent-date-value">Mar 15, 1988</td><td class="patent-data-table-td ">Healthware Corporation</td><td class="patent-data-table-td ">Patient-operated glucose monitor and diabetes management system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4753652">US4753652</a></td><td class="patent-data-table-td patent-date-value">Dec 10, 1986</td><td class="patent-data-table-td patent-date-value">Jun 28, 1988</td><td class="patent-data-table-td ">Children&#39;s Medical Center Corporation</td><td class="patent-data-table-td ">Biomaterial implants which resist calcification</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4757022">US4757022</a></td><td class="patent-data-table-td patent-date-value">Nov 19, 1987</td><td class="patent-data-table-td patent-date-value">Jul 12, 1988</td><td class="patent-data-table-td ">Markwell Medical Institute, Inc.</td><td class="patent-data-table-td ">Biological fluid measuring device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4759828">US4759828</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 1987</td><td class="patent-data-table-td patent-date-value">Jul 26, 1988</td><td class="patent-data-table-td ">Nova Biomedical Corporation</td><td class="patent-data-table-td ">Glucose electrode and method of determining glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4776944">US4776944</a></td><td class="patent-data-table-td patent-date-value">Sep 1, 1987</td><td class="patent-data-table-td patent-date-value">Oct 11, 1988</td><td class="patent-data-table-td ">Jiri Janata</td><td class="patent-data-table-td ">Solid state electrochemical detectors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4781798">US4781798</a></td><td class="patent-data-table-td patent-date-value">May 8, 1987</td><td class="patent-data-table-td patent-date-value">Nov 1, 1988</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Transparent multi-oxygen sensor array and method of using same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4787398">US4787398</a></td><td class="patent-data-table-td patent-date-value">Jul 25, 1986</td><td class="patent-data-table-td patent-date-value">Nov 29, 1988</td><td class="patent-data-table-td ">Garid, Inc.</td><td class="patent-data-table-td ">Glucose medical monitoring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4803243">US4803243</a></td><td class="patent-data-table-td patent-date-value">Mar 25, 1987</td><td class="patent-data-table-td patent-date-value">Feb 7, 1989</td><td class="patent-data-table-td ">Shin-Etsu Chemical Co., Ltd.</td><td class="patent-data-table-td ">Block-graft copolymer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4805625">US4805625</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 1987</td><td class="patent-data-table-td patent-date-value">Feb 21, 1989</td><td class="patent-data-table-td ">Ad-Tech Medical Instrument Corporation</td><td class="patent-data-table-td ">Sphenoidal electrode and insertion method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4810470">US4810470</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 1987</td><td class="patent-data-table-td patent-date-value">Mar 7, 1989</td><td class="patent-data-table-td ">Miles Inc.</td><td class="patent-data-table-td ">Volume independent diagnostic device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4823808">US4823808</a></td><td class="patent-data-table-td patent-date-value">Jul 6, 1987</td><td class="patent-data-table-td patent-date-value">Apr 25, 1989</td><td class="patent-data-table-td ">Clegg Charles T</td><td class="patent-data-table-td ">Method for control of obesity, overweight and eating disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4852573">US4852573</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 1987</td><td class="patent-data-table-td patent-date-value">Aug 1, 1989</td><td class="patent-data-table-td ">Kennedy Philip R</td><td class="patent-data-table-td ">Implantable neural electrode</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4861830">US4861830</a></td><td class="patent-data-table-td patent-date-value">Jun 22, 1987</td><td class="patent-data-table-td patent-date-value">Aug 29, 1989</td><td class="patent-data-table-td ">Th. Goldschmidt Ag</td><td class="patent-data-table-td ">Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4871440">US4871440</a></td><td class="patent-data-table-td patent-date-value">Jul 6, 1988</td><td class="patent-data-table-td patent-date-value">Oct 3, 1989</td><td class="patent-data-table-td ">Daiken Industries, Ltd.</td><td class="patent-data-table-td ">Enzyme electrode;elecric signal generated to measure amount of reaction product produced or lost</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4883057">US4883057</a></td><td class="patent-data-table-td patent-date-value">Sep 9, 1986</td><td class="patent-data-table-td patent-date-value">Nov 28, 1989</td><td class="patent-data-table-td ">Research Foundation, The City University Of New York</td><td class="patent-data-table-td ">Cathodic electrochemical current arrangement with telemetric application</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4889744">US4889744</a></td><td class="patent-data-table-td patent-date-value">May 2, 1988</td><td class="patent-data-table-td patent-date-value">Dec 26, 1989</td><td class="patent-data-table-td ">Medical Products Development Inc.</td><td class="patent-data-table-td ">Mixing particles and silicone; curing; dissolving out silicone</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4890620">US4890620</a></td><td class="patent-data-table-td patent-date-value">Feb 17, 1988</td><td class="patent-data-table-td patent-date-value">Jan 2, 1990</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Two-dimensional diffusion glucose substrate sensing electrode</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4902294">US4902294</a></td><td class="patent-data-table-td patent-date-value">Nov 30, 1987</td><td class="patent-data-table-td patent-date-value">Feb 20, 1990</td><td class="patent-data-table-td ">Olivier Gosserez</td><td class="patent-data-table-td ">Implantable mammary prosthesis adapted to combat the formation of a retractile shell</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4927407">US4927407</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 1989</td><td class="patent-data-table-td patent-date-value">May 22, 1990</td><td class="patent-data-table-td ">Regents Of The University Of Minnesota</td><td class="patent-data-table-td ">Cardiac assist pump with steady rate supply of fluid lubricant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4935345">US4935345</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 1987</td><td class="patent-data-table-td patent-date-value">Jun 19, 1990</td><td class="patent-data-table-td ">Arizona Board Of Regents</td><td class="patent-data-table-td ">Implantable microelectronic biochemical sensor incorporating thin film thermopile</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4953552">US4953552</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 1989</td><td class="patent-data-table-td patent-date-value">Sep 4, 1990</td><td class="patent-data-table-td ">Demarzo Arthur P</td><td class="patent-data-table-td ">Blood glucose monitoring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4963595">US4963595</a></td><td class="patent-data-table-td patent-date-value">Dec 22, 1988</td><td class="patent-data-table-td patent-date-value">Oct 16, 1990</td><td class="patent-data-table-td ">Thoratec Laboratories Corporation</td><td class="patent-data-table-td ">Polysiloxane-polylactone block copolymers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4970145">US4970145</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 20, 1988</td><td class="patent-data-table-td patent-date-value">Nov 13, 1990</td><td class="patent-data-table-td ">Cambridge Life Sciences Plc</td><td class="patent-data-table-td ">Carbon or graphite particles in resin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4984929">US4984929</a></td><td class="patent-data-table-td patent-date-value">May 16, 1989</td><td class="patent-data-table-td patent-date-value">Jan 15, 1991</td><td class="patent-data-table-td ">Julius Blum Gesellschaft M.B.H.</td><td class="patent-data-table-td ">Fitting for fastening the rail member of a drawer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4986271">US4986271</a></td><td class="patent-data-table-td patent-date-value">Jul 19, 1989</td><td class="patent-data-table-td patent-date-value">Jan 22, 1991</td><td class="patent-data-table-td ">The University Of New Mexico</td><td class="patent-data-table-td ">Vivo refillable glucose sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4986671">US4986671</a></td><td class="patent-data-table-td patent-date-value">Apr 12, 1989</td><td class="patent-data-table-td patent-date-value">Jan 22, 1991</td><td class="patent-data-table-td ">Luxtron Corporation</td><td class="patent-data-table-td ">Three-parameter optical fiber sensor and system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4994167">US4994167</a></td><td class="patent-data-table-td patent-date-value">Jul 7, 1988</td><td class="patent-data-table-td patent-date-value">Feb 19, 1991</td><td class="patent-data-table-td ">Markwell Medical Institute, Inc.</td><td class="patent-data-table-td ">Biological fluid measuring device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5002572">US5002572</a></td><td class="patent-data-table-td patent-date-value">Nov 22, 1988</td><td class="patent-data-table-td patent-date-value">Mar 26, 1991</td><td class="patent-data-table-td ">Picha George J</td><td class="patent-data-table-td ">Biological implant with textured surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5007929">US5007929</a></td><td class="patent-data-table-td patent-date-value">Jul 27, 1990</td><td class="patent-data-table-td patent-date-value">Apr 16, 1991</td><td class="patent-data-table-td ">Medical Products Development, Inc.</td><td class="patent-data-table-td ">Open-cell, silicone-elastomer medical implant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5050612">US5050612</a></td><td class="patent-data-table-td patent-date-value">Sep 12, 1989</td><td class="patent-data-table-td patent-date-value">Sep 24, 1991</td><td class="patent-data-table-td ">Matsumura Kenneth N</td><td class="patent-data-table-td ">Device for computer-assisted monitoring of the body</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5059654">US5059654</a></td><td class="patent-data-table-td patent-date-value">Feb 16, 1989</td><td class="patent-data-table-td patent-date-value">Oct 22, 1991</td><td class="patent-data-table-td ">Cuno Inc.</td><td class="patent-data-table-td ">Affinity matrices of modified polysaccharide supports</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5067491">US5067491</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 1989</td><td class="patent-data-table-td patent-date-value">Nov 26, 1991</td><td class="patent-data-table-td ">Becton, Dickinson And Company</td><td class="patent-data-table-td ">Barrier coating on blood contacting devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5101814">US5101814</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 1989</td><td class="patent-data-table-td patent-date-value">Apr 7, 1992</td><td class="patent-data-table-td ">Palti Yoram Prof</td><td class="patent-data-table-td ">System for monitoring and controlling blood glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5113871">US5113871</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 1988</td><td class="patent-data-table-td patent-date-value">May 19, 1992</td><td class="patent-data-table-td ">Jouko Viljanto</td><td class="patent-data-table-td ">Device for the determination of incisional wound healing ability</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5130231">US5130231</a></td><td class="patent-data-table-td patent-date-value">Jun 12, 1989</td><td class="patent-data-table-td patent-date-value">Jul 14, 1992</td><td class="patent-data-table-td ">Chem-Elec, Inc.</td><td class="patent-data-table-td ">Blood plasma test device including a semipermeable membrane made of an expanded hydrophobic material that has been treated with a surfactant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5137028">US5137028</a></td><td class="patent-data-table-td patent-date-value">Oct 16, 1990</td><td class="patent-data-table-td patent-date-value">Aug 11, 1992</td><td class="patent-data-table-td ">Nishimoto, Co., Ltd.</td><td class="patent-data-table-td ">Clinical thermometer for women</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5165407">US5165407</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 1991</td><td class="patent-data-table-td patent-date-value">Nov 24, 1992</td><td class="patent-data-table-td ">The University Of Kansas</td><td class="patent-data-table-td ">Implantable glucose sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5171689">US5171689</a></td><td class="patent-data-table-td patent-date-value">Apr 18, 1989</td><td class="patent-data-table-td patent-date-value">Dec 15, 1992</td><td class="patent-data-table-td ">Matsushita Electric Industrial Co., Ltd.</td><td class="patent-data-table-td ">Electrochemical analyzer using enzymes and oxidizing dyes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5190041">US5190041</a></td><td class="patent-data-table-td patent-date-value">Dec 27, 1991</td><td class="patent-data-table-td patent-date-value">Mar 2, 1993</td><td class="patent-data-table-td ">Palti Yoram Prof</td><td class="patent-data-table-td ">System for monitoring and controlling blood glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5222980">US5222980</a></td><td class="patent-data-table-td patent-date-value">Sep 27, 1991</td><td class="patent-data-table-td patent-date-value">Jun 29, 1993</td><td class="patent-data-table-td ">Medtronic, Inc.</td><td class="patent-data-table-td ">Implantable heart-assist device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5235003">US5235003</a></td><td class="patent-data-table-td patent-date-value">Aug 31, 1990</td><td class="patent-data-table-td patent-date-value">Aug 10, 1993</td><td class="patent-data-table-td ">Thoratec Laboratories Corporation</td><td class="patent-data-table-td ">Surface modifying additives for polymers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5249576">US5249576</a></td><td class="patent-data-table-td patent-date-value">Oct 24, 1991</td><td class="patent-data-table-td patent-date-value">Oct 5, 1993</td><td class="patent-data-table-td ">Boc Health Care, Inc.</td><td class="patent-data-table-td ">Universal pulse oximeter probe</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5264104">US5264104</a></td><td class="patent-data-table-td patent-date-value">May 8, 1992</td><td class="patent-data-table-td patent-date-value">Nov 23, 1993</td><td class="patent-data-table-td ">Gregg Brian A</td><td class="patent-data-table-td ">Three-dimensional polymer networks bound to enzymes; protein excluding</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5269891">US5269891</a></td><td class="patent-data-table-td patent-date-value">Jan 26, 1993</td><td class="patent-data-table-td patent-date-value">Dec 14, 1993</td><td class="patent-data-table-td ">Novo Nordisk A/S</td><td class="patent-data-table-td ">Amperemetric blood fluid analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5271736">US5271736</a></td><td class="patent-data-table-td patent-date-value">Sep 25, 1992</td><td class="patent-data-table-td patent-date-value">Dec 21, 1993</td><td class="patent-data-table-td ">Applied Medical Research</td><td class="patent-data-table-td ">Collagen disruptive morphology for implants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5282848">US5282848</a></td><td class="patent-data-table-td patent-date-value">Apr 19, 1993</td><td class="patent-data-table-td patent-date-value">Feb 1, 1994</td><td class="patent-data-table-td ">Meadox Medicals, Inc.</td><td class="patent-data-table-td ">Self-supporting woven vascular graft</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5285513">US5285513</a></td><td class="patent-data-table-td patent-date-value">Nov 30, 1992</td><td class="patent-data-table-td patent-date-value">Feb 8, 1994</td><td class="patent-data-table-td ">At&amp;T Bell Laboratories</td><td class="patent-data-table-td ">Composition disposed about coated fibers including a hydrocarbon, a block copolymer, a colloidal filler and an antioxidant system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5299571">US5299571</a></td><td class="patent-data-table-td patent-date-value">Jan 22, 1993</td><td class="patent-data-table-td patent-date-value">Apr 5, 1994</td><td class="patent-data-table-td ">Eli Lilly And Company</td><td class="patent-data-table-td ">Beneath the skin surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5304468">US5304468</a></td><td class="patent-data-table-td patent-date-value">Jan 26, 1993</td><td class="patent-data-table-td patent-date-value">Apr 19, 1994</td><td class="patent-data-table-td ">Lifescan, Inc.</td><td class="patent-data-table-td ">Reagent test strip and apparatus for determination of blood glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5310469">US5310469</a></td><td class="patent-data-table-td patent-date-value">Dec 31, 1991</td><td class="patent-data-table-td patent-date-value">May 10, 1994</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Apparatus for quantitative analysis, dielectric housings, conductors for currents, membranes, substrates and molecules with active material attached</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5314471">US5314471</a></td><td class="patent-data-table-td patent-date-value">Apr 1, 1992</td><td class="patent-data-table-td patent-date-value">May 24, 1994</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Tissue inplant systems and methods for sustaining viable high cell densities within a host</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5316008">US5316008</a></td><td class="patent-data-table-td patent-date-value">Apr 3, 1991</td><td class="patent-data-table-td patent-date-value">May 31, 1994</td><td class="patent-data-table-td ">Casio Computer Co., Ltd.</td><td class="patent-data-table-td ">Measurement of electrocardiographic wave and sphygmus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5321414">US5321414</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 1993</td><td class="patent-data-table-td patent-date-value">Jun 14, 1994</td><td class="patent-data-table-td ">Her Majesty In Right Of Canada As Represented By The Minister Of Communications</td><td class="patent-data-table-td ">Dual polarization dipole array antenna</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5804048">US5804048</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 15, 1996</td><td class="patent-data-table-td patent-date-value">Sep 8, 1998</td><td class="patent-data-table-td ">Via Medical Corporation</td><td class="patent-data-table-td ">Electrode assembly for assaying glucose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6528584">US6528584</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 12, 2001</td><td class="patent-data-table-td patent-date-value">Mar 4, 2003</td><td class="patent-data-table-td ">The University Of Akron</td><td class="patent-data-table-td ">Multi-component polymeric networks containing poly(ethylene glycol)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20030059631">US20030059631</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 29, 2000</td><td class="patent-data-table-td patent-date-value">Mar 27, 2003</td><td class="patent-data-table-td ">Al-Lamee Kadam Gayad</td><td class="patent-data-table-td ">Biocompatible medical articles and process for their production</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USRE31916">USRE31916</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 1981</td><td class="patent-data-table-td patent-date-value">Jun 18, 1985</td><td class="patent-data-table-td ">Becton Dickinson &amp; Company</td><td class="patent-data-table-td ">Electrochemical detection cell</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Answers.com. "<a href='http://scholar.google.com/scholar?q="xenogenic."'>xenogenic.</a>" The American Heritage Stedman's Medical Dictionary. Houghton Mifflin Company, 2002. Answers.com Nov. 7, 2006 http://www.Answers.com/topic/<a href='http://scholar.google.com/scholar?q="xenogenic."'>xenogenic.</a></td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Armour, et al. Dec. 1990. Application of Chronic Intravascular Blood Glucose Sensor in Dogs. Diabetes 39:1519-1526.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Atanasov, et al. Biosensor for Continuous Glucose Monitoring. Biotechnology and Bioengineering 1994, 43, 262-266.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Baker, et al. Dynamic concentration challenges for biosensor characterization. Biosens Bioelectron 1993, 8, 433-441.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bani Amer, M. M. An accurate amperometric glucose sensor based glucometer with eliminated cross-sensitivity. J Med Eng Technol 2002, 26, 208-13.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Beach, et al. Subminiature implantable potentiostat and modified commercial telemetry device for remote glucose monitoring. IEEE Transactions on Instrumentation and Measurement 1999, 48, 1239-1245.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bindra et al. 1991. Design and In Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring. Anal. Chem 63:1692-96.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bindra, et al. Pulsed amperometric detection of glucose in biological fluids at a surface-modified gold electrode. Anal Chem 1989, 61, 2566-2570.</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bode, B. W. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther 2000, 2 Suppl 1, S35-41.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bode, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999, 46, 183-190.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bode, et al. Using the continuous glucose monitoring system to improve the management of type 1 diabetes. Diabetes Technol Ther 2000, 2 Suppl 1, S43-8.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bott, A. W. A Comparison of Cyclic Voltammetryand Cyclic Staircase Voltammetry. Current Separations 1997, 16:1, 23-26.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brauker, et al. Jun. 27, 1996. Local Inflammatory Response Around Diffusion Chambers Containing Xenografts Transplantation 61(12):1671-1677.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brauker, et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 1995, 29, 1517-1524.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brauker, et al. Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Hum Gene Ther 1998, 9, 879-888.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brauker, J., Abstract: Neovascularization of Cell Transplantation Devices: Membrane Architecture-Driven an Implanted Tissue-Driven Vascularization. Baxter Healthcare Corp.</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brauker, J.H. Unraveling Mysteries at the Biointerface: Molecular Mediator of Inhibition of Blood Vessel Formation in the Foreign Body Capsule Revealed. Surfacts Biomaterials 2001,6, 1;5.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bremer, et al. Benchmark data from the literature for evaluation of new glucose sensing technologies. Diabetes Technol Ther 2001, 3, 409-418.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brunner, et al. Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care 1998, 21, 585-590.</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">D'Arrigo, et al. Porous-Si based bioreactors for glucose monitoring and drugs production. Proc. of SPIE 2003, 4982, 178-184.</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Direct 30/30(R) meter (Markwell Medical) (Catalog), date unknown.</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Dixon, et al. Characterization in vitro and in vivo of the oxygen dependence of an enzyme/polymer biosensor for monitoring brain glucose. J Neurosci Methods 2002, 119, 135-142.</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">DuPont1 Dimension AR(R) (Catalog), date unknown.</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ernst, et al. Reliable glucose monitoring through the use of microsystem technology. Anal Bioanal Chem 2002, 373, 758-761.</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Fare, et al. Functional characterization of a conducting polymer-based immunoassay system. Biosens Bioelectron 1998, 13, 459-470.</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Fischer et al. 1989. Oxygen Tension at the Subcutaneous Implantation Site of Glucose Sensors. Biomed. Biochem 11/12:965-972.</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Frost, et al. Implantable chemical sensors for real-time clinical monitoring: progress and challenges. Curr Opin Chem Biol 2002, 6, 633-641.</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Geller, et al. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Ann NY Acad Sci 1997, 831, 438-451.</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gerritsen, et al. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res 2001, 54, 69-75.</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gerritsen, et al. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med 1999, 54, 167-179.</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gerritsen, M. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care 2000, 23, 143-5.</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gilligan et al. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 1994, 17:8, 882-887.</td></tr><tr><td class="patent-data-table-td ">33</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gough, et al. Immobilized glucose oxidase in implantable glucose sensor technology. Diabetes Technol Ther 2000, 2, 377-380.</td></tr><tr><td class="patent-data-table-td ">34</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gross, et al. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000, 2 Suppl 1, S19-26.</td></tr><tr><td class="patent-data-table-td ">35</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gross, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000, 2, 49-56.</td></tr><tr><td class="patent-data-table-td ">36</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gross, Todd, "<a href='http://scholar.google.com/scholar?q="Letters+to+the+Editor+Re%3A+Diabetes+Technology+%26amp%3B+Therapeutics%2C+2000%3B2%3A49-56%2C"'>Letters to the Editor Re: Diabetes Technology &amp; Therapeutics, 2000;2:49-56,</a>" vol. 3, No. 1, p. 130-131, 2001.</td></tr><tr><td class="patent-data-table-td ">37</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part 1. An adsorption-controlled mechanism. Electrochimica Acta 1998, 43, 579-588.</td></tr><tr><td class="patent-data-table-td ">38</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part II: effect of potential. Electrochimica Acta 1998, 43, 2015-2024.</td></tr><tr><td class="patent-data-table-td ">39</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part III: Effect of temperature. Electrochimica Acta 1999, 44, 2455-2462.</td></tr><tr><td class="patent-data-table-td ">40</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part IV: phosphate buffer dependence. Electrochimica Acta 1999, 44, 4573-4582.</td></tr><tr><td class="patent-data-table-td ">41</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hall, et al. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part V: inhibition by chloride. Electrochimica Acta 2000, 45, 3573-3579.</td></tr><tr><td class="patent-data-table-td ">42</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hitchman, M. Measurement of Dissolved Oxygen. Chemical Analysis 1978, 49, 34-123.</td></tr><tr><td class="patent-data-table-td ">43</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Huang, C., O'Grady, W.E.; Yeager, E. Electrochemical Generation of Oxygen. 1: The Effects of Anions and Cations on Hydrogen Chemisorption and Aniodic Oxide Film Formation on Platinum Electrode. 2: The Effects of Anions and Cations on Oxygen Generation on Platinum Electrode, pp. 1-116, Aug. 1975.</td></tr><tr><td class="patent-data-table-td ">44</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">IPER for PCT/US02/23902 filed Jul. 26, 2002.</td></tr><tr><td class="patent-data-table-td ">45</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">ISR for PCT/US02/23902 filed Jul. 26, 2002.</td></tr><tr><td class="patent-data-table-td ">46</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Jensen, et al. Fast Wave Forms for Pulsed Electrochemical Detection of Glucose by Incorporation of Reduction Desorption of Oxidation Products. Analytical Chemistry 1997, 69, 1776-1781.</td></tr><tr><td class="patent-data-table-td ">47</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Johnson, et al. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosens Bioelectron 1992, 7, 709-714.</td></tr><tr><td class="patent-data-table-td ">48</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Jovanovic, L. The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technol Ther 2000, 2 Suppl 1, S67-71.</td></tr><tr><td class="patent-data-table-td ">49</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kargol, et al. Studies on the structural properties of porous membranes: measurement of linear dimensions of solutes. Biophys Chem 2001, 91, 263-271.</td></tr><tr><td class="patent-data-table-td ">50</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kaufman, F. R. Role of the continuous glucose monitoring system in pediatric patients. Diabetes Technol Ther 2000, 2 Suppl 1, S49-52.</td></tr><tr><td class="patent-data-table-td ">51</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kiechle, F.L. The impact of continuous glucose monitoring on hospital point-of-care testing programs. Diabetes Technol Ther 2001, 3, 647-649.</td></tr><tr><td class="patent-data-table-td ">52</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Koschinsky, et al. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev 2001, 17, 113-123.</td></tr><tr><td class="patent-data-table-td ">53</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kruger, et al. Psychological motivation and patient education: a role for continuous glucose monitoring. Diabetes Technol Ther 2000, 2 Suppl 1, S93-7.</td></tr><tr><td class="patent-data-table-td ">54</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lee, et al. Effects of pore size, void volume, and pore connectivity on tissue responses. Society for Biomaterials 1999, 25th Annual Meeting, 171.</td></tr><tr><td class="patent-data-table-td ">55</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lerner, et al. An implantable electrochemical glucose sensor. Ann N Y Acad Sci 1984, 428, 263-278.</td></tr><tr><td class="patent-data-table-td ">56</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Leypoldt, et al. Model of a two-substrate enzyme electrode for glucose. Anal Chem 1984, 56, 2896-2904.</td></tr><tr><td class="patent-data-table-td ">57</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Loffler, et al. 1995. Separation and determination of traces of ammonia in air by means of chromatomembrane cells. Fresenius J Anal Chem 352:613-614.</td></tr><tr><td class="patent-data-table-td ">58</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">lshikawa, et al. Initial evaluation of a 290-microm diameter subcutaneous glucose sensor: glucose monitoring with a biocompatible, flexible-wire, enzyme-based amperometric microsensor in diabetic and nondiabetic humans. J Diabetes Complications 1998, 12, 295-301.</td></tr><tr><td class="patent-data-table-td ">59</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lyman D. 1960. Polyurethanes. I. The Solution Polymerization of Diisocyanates with Ethylene Glycol. J. Polymer Sci XLV:45:49.</td></tr><tr><td class="patent-data-table-td ">60</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Makale, et al. Tissue window chamber system for validation of implanted oxygen sensors. Am J Physiol Heart Circ Physiol 2003, 284, 1-24.</td></tr><tr><td class="patent-data-table-td ">61</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Malin, et al. Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectroscopy. Clinical Chemistry, 45:9, 1651-1658, 1999.</td></tr><tr><td class="patent-data-table-td ">62</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">McKean, et al. Jul. 7, 1988. A Telemetry Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors. Transactions on Biomedical Engineering 35:526-532.</td></tr><tr><td class="patent-data-table-td ">63</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Apr. 4, 2006 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">64</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Apr. 9, 2003 in U.S. Appl. No. 09/916,386.</td></tr><tr><td class="patent-data-table-td ">65</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Aug. 1, 2006 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">66</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Aug. 14, 2001 in U.S. Appl. No. 09/489,588.</td></tr><tr><td class="patent-data-table-td ">67</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Aug. 14, 2006 in U.S. Appl. No. 11/039,269.</td></tr><tr><td class="patent-data-table-td ">68</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Aug. 15, 2001 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">69</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Dec. 7, 1998 in U.S. Appl. No. 08/811,473.</td></tr><tr><td class="patent-data-table-td ">70</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Feb. 24, 2006 in U.S. Appl. No. 10/646,333.</td></tr><tr><td class="patent-data-table-td ">71</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Feb. 24, 2006 in U.S. Appl. No. 11/039,269.</td></tr><tr><td class="patent-data-table-td ">72</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Feb. 27, 2002 in U.S. Appl. No. 09/489,588.</td></tr><tr><td class="patent-data-table-td ">73</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jan. 16, 2003 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">74</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jan. 17, 2002 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">75</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jul. 15, 2002 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">76</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jul. 17, 2007 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">77</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jul. 9, 2003 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">78</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jun. 12, 2003 in U.S. Appl. No. 09/489,588.</td></tr><tr><td class="patent-data-table-td ">79</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Jun. 6, 2003 in U.S. Appl. No. 10/646,333.</td></tr><tr><td class="patent-data-table-td ">80</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Mar. 22, 2004 in U.S. Appl. No. 09/916,858.</td></tr><tr><td class="patent-data-table-td ">81</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Mar. 9, 2007 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">82</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated May 23, 2007 in U.S. Appl. No. 11/055,779.</td></tr><tr><td class="patent-data-table-td ">83</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated May 4, 2005 in U.S. Appl. No. 11/039,269.</td></tr><tr><td class="patent-data-table-td ">84</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Nov. 2, 2005 in U.S. Appl. No. 11/039,269.</td></tr><tr><td class="patent-data-table-td ">85</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Nov. 28, 2003 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">86</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Oct. 16, 2006 in U.S. Appl. No. 10/647,065.</td></tr><tr><td class="patent-data-table-td ">87</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Sep. 21, 2004 in U.S. Appl. No. 09/916,858.</td></tr><tr><td class="patent-data-table-td ">88</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Sep. 21, 2004 in U.S. Appl. No. 10/657,843.</td></tr><tr><td class="patent-data-table-td ">89</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Sep. 21, 2007 in U.S. Appl. No. 10/838,912.</td></tr><tr><td class="patent-data-table-td ">90</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Sep. 22, 2004 in U.S. Appl. No. 10/646,333.</td></tr><tr><td class="patent-data-table-td ">91</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Office Action dated Sep. 22, 2005 in U.S. Appl. No. 09/447,227.</td></tr><tr><td class="patent-data-table-td ">92</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Phillips and Smith. 1988. Bromedical Applications of Polyurethanes: Implications of Failure Mechanisms. J. Biomat. Appl. 3:202-227.</td></tr><tr><td class="patent-data-table-td ">93</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Pineda, et al. 1996. Bone regeneration with resorbable polymeric membranes. III. Effect of poly(L-lactide) membrane pore size on the bone healing process in large defects. J. Biomedical Materials Research 31:385-394.</td></tr><tr><td class="patent-data-table-td ">94</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shichiri, et al. 1986. Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals. Diabetes Care, Inc. 9(3):208-301.</td></tr><tr><td class="patent-data-table-td ">95</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stokes. 1988. Polyether Polyurethanes: Biostable or Not? J. Biomat. Appl. 3:228-259.</td></tr><tr><td class="patent-data-table-td ">96</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tse and Gough. 1987. Time-Dependent Inactivation of Immobilized Glucose Oxidase and Catalase. Biotechnol. Bioeng. 29:705-713.</td></tr><tr><td class="patent-data-table-td ">97</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Updike et al. 1988. Laboratory Evaluation of New Reusable Blood Glucose Sensor. Diabetes Care 11:801-807.</td></tr><tr><td class="patent-data-table-td ">98</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Updike, et al. 1982. Implanting the glucose enzyme electrode: Problems, progress, and alternative solutions. Diabetes Care 5(3):207-212.</td></tr><tr><td class="patent-data-table-td ">99</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Woodward. 1982. How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensor. Diabetes Care 5:278-281.</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013152090A2?cl=en">WO2013152090A2</a></td><td class="patent-data-table-td patent-date-value">Apr 3, 2013</td><td class="patent-data-table-td patent-date-value">Oct 10, 2013</td><td class="patent-data-table-td ">Dexcom, Inc.</td><td class="patent-data-table-td ">Transcutaneous analyte sensors, applicators therefor, and associated methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013184566A2?cl=en">WO2013184566A2</a></td><td class="patent-data-table-td patent-date-value">Jun 3, 2013</td><td class="patent-data-table-td patent-date-value">Dec 12, 2013</td><td class="patent-data-table-td ">Dexcom, Inc.</td><td class="patent-data-table-td ">Systems and methods for processing analyte data and generating reports</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014004460A1?cl=en">WO2014004460A1</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2013</td><td class="patent-data-table-td patent-date-value">Jan 3, 2014</td><td class="patent-data-table-td ">Dexcom, Inc.</td><td class="patent-data-table-td ">Use of sensor redundancy to detect sensor failures</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014011488A2?cl=en">WO2014011488A2</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2013</td><td class="patent-data-table-td patent-date-value">Jan 16, 2014</td><td class="patent-data-table-td ">Dexcom, Inc.</td><td class="patent-data-table-td ">Systems and methods for leveraging smartphone features in continuous glucose monitoring</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014052080A1?cl=en">WO2014052080A1</a></td><td class="patent-data-table-td patent-date-value">Sep 16, 2013</td><td class="patent-data-table-td patent-date-value">Apr 3, 2014</td><td class="patent-data-table-td ">Dexcom, Inc.</td><td class="patent-data-table-td ">Zwitterion surface modifications for continuous sensors</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc600/defs600.htm&usg=AFQjCNGoRRWCr3AADgOfjOLv9kXGux4XKA#C600S309000">600/309</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc204/defs204.htm&usg=AFQjCNHL8TPoxDsMzGlkTDMe9ka8B3HVxA#C204S403070">204/403.07</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S023760">623/23.76</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc600/defs600.htm&usg=AFQjCNGoRRWCr3AADgOfjOLv9kXGux4XKA#C600S347000">600/347</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc204/defs204.htm&usg=AFQjCNHL8TPoxDsMzGlkTDMe9ka8B3HVxA#C204S415000">204/415</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc600/defs600.htm&usg=AFQjCNGoRRWCr3AADgOfjOLv9kXGux4XKA#C600S345000">600/345</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0027416000">G01N27/416</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031100000">A61L31/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12Q0001260000">C12Q1/26</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005145000">A61B5/145</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0027327000">G01N27/327</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0027400000">G01N27/40</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005147300">A61B5/1473</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0031140000">A61L31/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12Q0001540000">C12Q1/54</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005000000">A61B5/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61F0002020000">A61F2/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12M0001340000">C12M1/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12M0001400000">C12M1/40</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/14865">A61B5/14865</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/076">A61B5/076</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L31/14">A61L31/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B2562/02">A61B2562/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rcLxBQABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L31/10">A61L31/10</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61B5/07D</span>, <span class="nested-value">A61B5/1486B</span>, <span class="nested-value">A61L31/10</span>, <span class="nested-value">A61L31/14</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Mar 14, 2013</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 20, 2011</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 13 AND 16 ARE DETERMINED TO BE PATENTABLE AS AMENDED. CLAIMS 14, 15 AND 17, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE. NEW CLAIM 46 IS ADDED AND DETERMINED TO BE PATENTABLE. CLAIMS 1-12 AND 18-45 WERE NOT REEXAMINED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 21, 2010</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 5, 2010</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20100702</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 22, 2010</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 28, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">DEXCOM, INC., CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRAUKER, JAMES H.;TAPSAK, MARK A.;SHULTS, MARK C.;REEL/FRAME:023437/0500;SIGNING DATES FROM 20010917 TO 20011001</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U2Ldilz7MHzST1dKhLCFQcfJ8Ekhg\u0026id=rcLxBQABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U04tswOdn-XN1jfPAnC6YatiLE52Q\u0026id=rcLxBQABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U1eieWxAhRPGdLhmQx8iKXHG2hgzg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/utilized_with_implantable_glucose_sensor.pdf?id=rcLxBQABERAJ\u0026output=pdf\u0026sig=ACfU3U1ZoZdnGdbEcrJXDwXO5xrzFYyLCQ"},"sample_url":"http://www.google.com/patents/reader?id=rcLxBQABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>